{
  "directed": true,
  "graph": {
    "annotation_list": {
      "Condition": [
        "early moderate stage",
        "increasing severity"
      ],
      "Published": [
        "CDR story"
      ]
    },
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
    },
    "document_metadata": {
      "authors": "Lukas Beniusis, Charles Tapley Hoyt, and Daniel Domingo-Fernández",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved",
      "description": "Literature Associations between the Clinical Dementia Rating Sum of Boxes (CDR-SB) and biological entities related to Alzheimer's disease",
      "licenses": "CC BY 4.0",
      "name": "CDR-SB Associations",
      "version": "1.0.5"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "InChI": ".*"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/3c93a65dc48e6786fe29ae55aa36cf9a902fe8c6/export/conso-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/f02c6ad4a4791a8ed45448513b9de8c8f1b00c87/external/mesh-names.belns",
      "MESHC": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh-chemicals/mesh-chemicals-20170511.belns",
      "NIFT": "https://raw.githubusercontent.com/neurommsig/neurommsig-terminology/c45db68bb47b28023ec134049429320da6a9d631/terminologies/neuroimaging-feature-terminology.belns",
      "SDIS": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-legacy-diseases/selventa-legacy-diseases-20150601.belns"
    },
    "namespaces_uncached": [],
    "path": "biomarkers/cdr_sb_associations.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "dfe3b09c3b97e7bb2eae417b771dd12f6c8322a3e31936a1d325978f1626456312f62fc2ddc5d76b7b7a7604713bbd630d0418e45bbeda6df1834933cfd2ad77",
      "line": 83,
      "relation": "equivalentTo",
      "source": 49,
      "target": 40
    },
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "928903612ca0e6fdd1a61342314e122c4aa9f5eace11c834ea76c271649c37b4303632e0dfc92c50264604626f745d3e872da20f0113946f763f6a3e505fa32d",
      "line": 84,
      "relation": "transcribedTo",
      "source": 49,
      "target": 90
    },
    {
      "key": "594389c6fa085ab640ae939f5b4cb12c2d0c51f5a0100e478f74663391803b3211c52e2f870b4382c5617a3b32e6e608e3d5a9be581f91e3d8468205d747751a",
      "relation": "hasVariant",
      "source": 48,
      "target": 49
    },
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "c82b4bd080a80034bf04178fc6d12dbccb16a7630508f698eeaa86e89993dcab24eeb6dfafe01a797e04c53c0f27c0f536dc51e34b6500377dbd2400f155aac6",
      "line": 83,
      "relation": "equivalentTo",
      "source": 40,
      "target": 49
    },
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "65bf3c25220cc46db02abefd739c6b2cda1253dab175a76d583595bfdb369f566f0f5dbacdddd3cc4bce76202b85489c3ef307e9d268518ab7890d7c840db7e8",
      "line": 85,
      "relation": "translatedTo",
      "source": 90,
      "target": 56
    },
    {
      "key": "8d921b4cf23c3a8f1329f4d6dd65396ff6f94c88541a93ccafced984e280508e9bb7fcebca72fbb4dada974f762bfae9a3557b1d368b5ea3a3cf0064ffcf277a",
      "relation": "hasVariant",
      "source": 89,
      "target": 90
    },
    {
      "key": "ee6dabb5ba051ab9d7700d0b9c6ceeff8141f029dc21c53858bc6e234dfa442083a0fd61eb9589a0632f4cc0f5ec9b51db679ee4f7f0af33a33787838e354528",
      "relation": "hasVariant",
      "source": 55,
      "target": 56
    },
    {
      "key": "f7da37064dc9f78c4616ac7fbb9d724638c2da825f641586912a70978e25b083ae6b473a96e1e59772ce69ac3bf99c627751cf9b8dad37c364f34fa2580fb71f",
      "relation": "hasVariant",
      "source": 51,
      "target": 37
    },
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "b8fae00957d90325bff5d6357335ba75b7cb44df1b4ac780ec166b2af1b147c0cd4b6e9b6e17bab81bc43acc4096696f3c2029287f6d08fc935bbc8a0488e30f",
      "line": 90,
      "relation": "isA",
      "source": 59,
      "target": 0
    },
    {
      "citation": {
        "authors": [
          "Bharath S",
          "Chandra SR",
          "Huded CB",
          "Sivakumar PT",
          "Subramanian S",
          "Varghese M"
        ],
        "date": "2015-02-01",
        "first": "Huded CB",
        "last": "Subramanian S",
        "name": "Asian journal of psychiatry",
        "pages": "44-7",
        "reference": "25468261",
        "title": "Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.",
        "type": "PubMed",
        "volume": "13"
      },
      "evidence": "The present study was undertaken to validate the measurement of biomarkers as a supplement to the latest diagnostic criteria for Alzheimer disease (AD) dementia by National Institute on Aging-Alzheimer's Association (NIA-AA) work group using a sample attending a tertiary care center in Southern India. A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study. The CSF biomarkers Abeta42, t-tau, and p-tau181 were assessed. The biomarker results were compared among mild and moderate to severe AD as defined in the NIA-AA work group guidelines. The results revealed that the amount of Abeta42 was very low in all the 20 samples (<50pg/ml) collected from mild AD cases with CDR score of 1 (n=8), and moderate to severe AD cases with CDR >1 (n=12). t-tau and p-tau levels were in the range of 39.45+/-5.09pg/ml and 13.06+/-7.32pg/ml for CDR 1 group. t-tau and p-tau levels were in the range of 49.9+/-11.28pg/ml and 33.94+/-15.13pg/ml for moderate to severe cases. Analysis of the data revealed statistically significant differences in the p-tau/t-tau ratio and p-tau/Abeta ratio between CDR 1and CDR >1 AD cases (p<0.001) suggesting that p-tau/t-tau and p-tau/Abeta ratio are good indicators of severity of dementia with discriminative value in differentiating mild AD from moderate to severe AD.",
      "key": "2a41789c46d5fe8d04ad87018d14092ee460a5322ba80fc5b2d369cdb6d55a4dec995daa8ca373543359a443bc55e508d7d097d979b1cb85eb190d98533dc5c2",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 59,
      "target": 4
    },
    {
      "key": "9d44773427e1eed6ab28c10287c0853b0b8f96cb18e386c11adda985c497a37ab8f1a9885e7aa89ae401eb253a13b5d15c3869f64a0290b2f3cb6785c37d289e",
      "relation": "hasVariant",
      "source": 57,
      "target": 59
    },
    {
      "key": "281b58c450e137e65feb6fb7075b0aa4a69373fa62487aa67346fc7d625a5fa7c596586234b370c0b9837a418315ab3165191673b9c726f29b976747a3859235",
      "relation": "hasVariant",
      "source": 57,
      "target": 58
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "7e25d138b0aec95ad3d9225c0ef8bbdd5481f44bab51b8f04b5a3d7a5b2189be4ca2175e555e5144697350f56d7d2df3e6ea8c5b5e1f886785793400a9461ecc",
      "line": 470,
      "relation": "regulates",
      "source": 57,
      "target": 57
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "720bfa1f8ef5e94de731a9c6f3f2accf3def42d6086162c2b0277e1640ec93c70c878c3436b98aee3560c5c65815f62c39fe6a8fb865704523070ce1faed7795",
      "line": 471,
      "relation": "regulates",
      "source": 57,
      "target": 60
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "afe1baf46d6e63f076e68dcde7c5516779161a45624c9d74548ca956948e5b2ac63e3219439c9e49a5645489b7515fc8ba8659db5585c9acdf3915c5a4048a6a",
      "line": 473,
      "relation": "regulates",
      "source": 57,
      "target": 68
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "32819b96ce20817ea4f5a0fd52a5b3fd571a2b3ca534983ddc6ff20694402f6ee2f5a332be35231f3d30599607342d84ec55de7535d4fdec97e57bf4c10c1304",
      "line": 474,
      "relation": "regulates",
      "source": 57,
      "target": 66
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "83ad72ac37e10c491b7b7f16d54a605c54a3e2ccfed8cf9a65aeee86e6facfd707c58ad4edcb7944c6731b3c8693c044975df16a180e64fe220808704ddeebac",
      "line": 475,
      "relation": "regulates",
      "source": 57,
      "target": 83
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "811f9ede721cef179d9478b9fef364b9ca0798b564b102a9c6fed4554c8153a72399fb21817b24799c2f4bcf5ebd76a75a10bbc94074a9ca4029ae5b36aa92f9",
      "line": 477,
      "relation": "regulates",
      "source": 57,
      "target": 81
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "967c4af74202fc4d252fa25867d98a4f1cc121ed2a0aca09b747d0407cf88459a999c23ca6d51ce5327ee72a795ce4dcc7150c1131cfa225a888ce10cecea31f",
      "line": 479,
      "relation": "regulates",
      "source": 57,
      "target": 62
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "e1263bd22b098683930416a7d7ba3489352b771b691d6a8a5508e1fcbdf52a3aeb7fd5c99a196a1e38e2f406bce74de85b62025e72bdc0cf58d3a2245d4c7995",
      "line": 481,
      "relation": "regulates",
      "source": 57,
      "target": 75
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "d400042410a6e5a17104be1cd35e7c1797ca9d1e89e1a4b26ae7a7684bc7c8097fa9e0b1d24a3b5d9e509af8972584400657e28e900715205242d3a27aa7a22e",
      "line": 483,
      "relation": "regulates",
      "source": 57,
      "target": 82
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "eec29a5a3908e46f170d5b55806a47c53c1aa3fcd77c39df884d1fb013f019f466fb200bb1d4cba3548bfcfc798ad52d8516936203c0202873e44ce05d845eba",
      "line": 485,
      "relation": "regulates",
      "source": 57,
      "target": 53
    },
    {
      "citation": {
        "authors": [
          "Chang KA",
          "Suh YH"
        ],
        "date": "2010-10-01",
        "first": "Chang KA",
        "last": "Suh YH",
        "name": "BMB reports",
        "pages": "656-63",
        "reference": "21034527",
        "title": "Possible roles of amyloid intracellular domain of amyloid precursor protein.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "Although the role of AICD as a gene transcription inducer is still controversial, several targets of AICD- or APP-mediated transcriptional activation are reportedly regulated by APP nuclear signaling, including APP itself, BACE, Tip60, GSK-3b¸, p53, Mn-SOD, KAI1, Neprilysin, transgelin, a2actin, S100a9, and other genes",
      "key": "ef4ced68cad8cf1bfc1de5c23b3e9891931c479351da3a17cb7f1112722246e29afa9eab6558b9fb8043e4156041a1181d25ef703f7baffa650995ac5da5b1a9",
      "line": 486,
      "relation": "regulates",
      "source": 57,
      "target": 78
    },
    {
      "citation": {
        "reference": "https://www.ncbi.nlm.nih.gov/clinvar/RCV000019448/",
        "type": "URL"
      },
      "evidence": "Extracted from ClinVar",
      "key": "34efbf7a977953491185249b1c435ef50b9523d08918317d01987db126e3ce6d57fdf6ff1f0b1e730bd86fab1a31894811586079606b2e3d16caa181d6bd0081",
      "line": 91,
      "relation": "isA",
      "source": 58,
      "target": 0
    },
    {
      "citation": {
        "authors": [
          "Bharath S",
          "Chandra SR",
          "Huded CB",
          "Sivakumar PT",
          "Subramanian S",
          "Varghese M"
        ],
        "date": "2015-02-01",
        "first": "Huded CB",
        "last": "Subramanian S",
        "name": "Asian journal of psychiatry",
        "pages": "44-7",
        "reference": "25468261",
        "title": "Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.",
        "type": "PubMed",
        "volume": "13"
      },
      "evidence": "The present study was undertaken to validate the measurement of biomarkers as a supplement to the latest diagnostic criteria for Alzheimer disease (AD) dementia by National Institute on Aging-Alzheimer's Association (NIA-AA) work group using a sample attending a tertiary care center in Southern India. A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study. The CSF biomarkers Abeta42, t-tau, and p-tau181 were assessed. The biomarker results were compared among mild and moderate to severe AD as defined in the NIA-AA work group guidelines. The results revealed that the amount of Abeta42 was very low in all the 20 samples (<50pg/ml) collected from mild AD cases with CDR score of 1 (n=8), and moderate to severe AD cases with CDR >1 (n=12). t-tau and p-tau levels were in the range of 39.45+/-5.09pg/ml and 13.06+/-7.32pg/ml for CDR 1 group. t-tau and p-tau levels were in the range of 49.9+/-11.28pg/ml and 33.94+/-15.13pg/ml for moderate to severe cases. Analysis of the data revealed statistically significant differences in the p-tau/t-tau ratio and p-tau/Abeta ratio between CDR 1and CDR >1 AD cases (p<0.001) suggesting that p-tau/t-tau and p-tau/Abeta ratio are good indicators of severity of dementia with discriminative value in differentiating mild AD from moderate to severe AD.",
      "key": "70fd51274e0cf78eca4c5088b46febf3fc71d9e78a7b83a4a82016f948036b983d3b99285247f8a2aba1476d65c8ebb48ceb325c5eb1af32f849d6a6f1320d80",
      "line": 98,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 59
    },
    {
      "citation": {
        "authors": [
          "Bharath S",
          "Chandra SR",
          "Huded CB",
          "Sivakumar PT",
          "Subramanian S",
          "Varghese M"
        ],
        "date": "2015-02-01",
        "first": "Huded CB",
        "last": "Subramanian S",
        "name": "Asian journal of psychiatry",
        "pages": "44-7",
        "reference": "25468261",
        "title": "Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.",
        "type": "PubMed",
        "volume": "13"
      },
      "evidence": "The present study was undertaken to validate the measurement of biomarkers as a supplement to the latest diagnostic criteria for Alzheimer disease (AD) dementia by National Institute on Aging-Alzheimer's Association (NIA-AA) work group using a sample attending a tertiary care center in Southern India. A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study. The CSF biomarkers Abeta42, t-tau, and p-tau181 were assessed. The biomarker results were compared among mild and moderate to severe AD as defined in the NIA-AA work group guidelines. The results revealed that the amount of Abeta42 was very low in all the 20 samples (<50pg/ml) collected from mild AD cases with CDR score of 1 (n=8), and moderate to severe AD cases with CDR >1 (n=12). t-tau and p-tau levels were in the range of 39.45+/-5.09pg/ml and 13.06+/-7.32pg/ml for CDR 1 group. t-tau and p-tau levels were in the range of 49.9+/-11.28pg/ml and 33.94+/-15.13pg/ml for moderate to severe cases. Analysis of the data revealed statistically significant differences in the p-tau/t-tau ratio and p-tau/Abeta ratio between CDR 1and CDR >1 AD cases (p<0.001) suggesting that p-tau/t-tau and p-tau/Abeta ratio are good indicators of severity of dementia with discriminative value in differentiating mild AD from moderate to severe AD.",
      "key": "ad6d01a0c0135dd6c6b657715a25cc41189388f2e0bf74e713f5545962c9e550777ea35f4001a495435461530e78527806a44d469fc71658daf7ee336c4ac424",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Alzheimer's Disease Neuroimaging Initiative.",
          "Breitner JC",
          "Corcoran C",
          "Crowley J",
          "Cruchaga C",
          "Goate AM",
          "Green RC",
          "Kauwe JS",
          "Lyketsos C",
          "Munger C",
          "Munger RG",
          "Norton MC",
          "Peterson D",
          "Tschanz J",
          "Welsh-Bohmer KA"
        ],
        "date": "2014-05-01",
        "first": "Peterson D",
        "last": "Kauwe JS",
        "name": "Alzheimer's &amp; dementia : the journal of the Alzheimer's Association",
        "pages": "366-71",
        "reference": "23727081",
        "title": "Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015). ",
      "key": "e6efb168cd8e2255eb630bc502c87807e39a040bdb689ec5ee1d6126ea6abe5a407f40549fdea096f9d7033fa09ae93d39b0b2460f84fd4de82dfcfd405edb8c",
      "line": 106,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 29
    },
    {
      "citation": {
        "authors": [
          "Belden CM",
          "Davis K",
          "Malek-Ahmadi M",
          "Sabbagh MN"
        ],
        "date": "2014-07-01",
        "first": "Malek-Ahmadi M",
        "last": "Sabbagh MN",
        "name": "Alzheimer disease and associated disorders",
        "pages": "296-8",
        "reference": "23138174",
        "title": "Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE.",
        "type": "PubMed",
        "volume": "28"
      },
      "evidence": "The Alzheimer Questionnaire (AQ) correlated strongly with the CDR Sum of Boxes (r=0.79) and demonstrated similar diagnostic accuracy with the MoCA and MMSE. These results suggest that the AQ is comparable with other established informant-based and patient-based measures. ",
      "key": "828bd3d258537133041aec514ffccef0034bb3115234bad6d178f6103265b30763be930f9336dbae77ede4a0fcf6ab72938b109a9c6c633df997992c4311f90b",
      "line": 202,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 11
    },
    {
      "citation": {
        "authors": [
          "Blanco A",
          "Coen RF",
          "Lawlor BA",
          "Lynch CA",
          "Moran M",
          "Walsh C",
          "Walsh JB"
        ],
        "date": "2006-01-01",
        "first": "Lynch CA",
        "last": "Lawlor BA",
        "name": "Dementia and geriatric cognitive disorders",
        "pages": "40-3",
        "reference": "16254429",
        "title": "The clinical dementia rating sum of box score in mild dementia.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "The Clinical Dementia Rating (CDR) scale is a widely used dementia staging instrument, yielding a global score and a summated score (sum of box score). ",
      "key": "74f5453b7756146cc5693cc6270fa53a0af9ee43f7326c0765cc3d465cb83e419e2e996e5a1f9fea4ad57e867a989e2f6ff9577639a315755ba173153d9dcfe2",
      "line": 238,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 14
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Lewy Body Disease": true,
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Becker JA",
          "Gomperts SN",
          "Growdon JH",
          "Hedden T",
          "Johnson KA",
          "Locascio JJ",
          "Marquie M",
          "Rentz DM"
        ],
        "date": "2014-01-01",
        "first": "Marquie M",
        "last": "Gomperts SN",
        "name": "Alzheimer's research &amp; therapy",
        "pages": "52",
        "reference": "25429309",
        "title": "Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.",
        "type": "PubMed",
        "volume": "6"
      },
      "evidence": "DAT concentration in putamen and in caudate were similar in PD and DLB groups and significantly lower than in HCS. Reduced caudate DAT concentration was associated with worse Clinical Dementia Rating Scale-sum of boxes (CDR-SB) scores and visuospatial skills in DLB but not in PD or HCS groups.",
      "key": "e5ac0a4a426bb0abff245374122b6157b932028959e260b929d69edca48f030d8eee19c6c4e3f588471710671aef6093322f01379aa32d9edf5970139677f4b3",
      "line": 257,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 15
    },
    {
      "citation": {
        "authors": [
          "Baldaçara L",
          "Borgio JG",
          "Bressan RA",
          "Jackowski AP",
          "Lacerda AL",
          "Montaño MB",
          "Moraes Wdos S",
          "Ramos LR",
          "Tufik S"
        ],
        "date": "2012-11-01",
        "first": "Borgio JG",
        "last": "Bressan RA",
        "name": "Arquivos de neuro-psiquiatria",
        "pages": "839-42",
        "reference": "23175194",
        "title": "Hippocampal volume and CDR-SB can predict conversion to dementia in MCI patients.",
        "type": "PubMed",
        "volume": "70"
      },
      "evidence": "OBJECTIVE: To evaluate the combination of two factors: clinical dementia rating sum of boxes scores (CDR-SB) and hippocampal volume (HV) as predictors of conversion from mild cognitive impairment (MCI) to dementia. METHODS: Twenty-eight individuals (9 normal and 19 with MCI) were classified according to their CDR sum of boxes scores into 3 groups. RESULTS: The hippocampal volume was significantly lower in the high-risk group and in those who developed dementia after two years. The rate of conversion was crescent among the three groups.",
      "key": "21b0cdbf0ccd1aeafc1368568f8b9c50418c07b0dc92709ab2096a3f43158013699ae491109aaa53326381557909776dba2da8b926d0273a4b54c33ad9a991e6",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 18
    },
    {
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Bishnoi RJ",
          "Palmer RF",
          "Royall DR"
        ],
        "date": "2015-07-01",
        "first": "Royall DR",
        "last": "Palmer RF",
        "name": "Neurobiology of aging",
        "pages": "2232-2240",
        "reference": "26043140",
        "title": "Serum IGF-BP2 strongly moderates age's effect on cognition: a MIMIC analysis.",
        "type": "PubMed",
        "volume": "36"
      },
      "evidence": "In this analysis, we construct a δ ortholog representing the 'cognitive correlates of age' (cAGE). cAGE largely mediates age's effects on dementia severity, as rated by the Clinical Dementia Rating Scale Sum of boxes and has an area under the receiver operating curve = 0.96 for the diagnosis of Alzheimer's Disease versus controls.",
      "key": "2c83d77bef228a746de79e189ebcccccd514f538336070e4d0ccd9d6100b1aea02cc957af8980216c9bc6593905d6950e061b8e5b54711f01bba3fda5cf449a3",
      "line": 338,
      "relation": "association",
      "source": 4,
      "target": 5
    },
    {
      "annotations": {
        "Anatomy": {
          "urine": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Among these three markers, the lower 3-HPMA/Cre ratio was most strongly correlated with the decline of MMSE (Mini-Mental State Examination) and the increase in CDRsob (Clinical Dementia Rating Scale Sum of Boxes Scores).",
      "key": "dc743fde90b693c6d0c33346b73520f527c7cf02d34030e509083375a359b4aa1b266488a53c3d7854e61e33dbafaeb3224d546e0098ff9fcb74e9234127b361",
      "line": 347,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 9
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Ahlijanian M",
          "Berisha F",
          "Boxer AL",
          "Coppola G",
          "Grinberg LT",
          "Hall T",
          "Karydas A",
          "Klepac K",
          "Kramer JH",
          "Meredith J Jr",
          "Miller BL",
          "Rabinovici G",
          "Rosen H",
          "Scherling CS",
          "Seeley W"
        ],
        "date": "2014-01-01",
        "first": "Scherling CS",
        "last": "Boxer AL",
        "name": "Annals of neurology",
        "pages": "116-26",
        "reference": "24242746",
        "title": "Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.",
        "type": "PubMed",
        "volume": "75"
      },
      "evidence": "CSF NfL, but not other CSF measures, correlated with CDRsb and neuropsychological measures in FTD, but not in other diagnostic groups.",
      "key": "b0adb65570eee0ca1b9753ce8fe84ea059837864bc5bd0ce3c1f00c32420be81c384efa239b35574dfec2b56bda4dba61f5fc8cf1e67cf1f0da9123eedcf6e54",
      "line": 371,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 76
    },
    {
      "annotations": {
        "Anatomy": {
          "caudate nucleus": true
        },
        "MeSHDisease": {
          "Lewy Body Disease": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Becker JA",
          "Gomperts SN",
          "Growdon JH",
          "Hedden T",
          "Johnson KA",
          "Locascio JJ",
          "Marquie M",
          "Rentz DM"
        ],
        "date": "2014-01-01",
        "first": "Marquie M",
        "last": "Gomperts SN",
        "name": "Alzheimer's research &amp; therapy",
        "pages": "52",
        "reference": "25429309",
        "title": "Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.",
        "type": "PubMed",
        "volume": "6"
      },
      "evidence": "Reduced caudate DAT concentration was associated with worse Clinical Dementia Rating Scale-sum of boxes (CDR-SB) scores and visuospatial skills in DLB but not in PD or HCS groups.",
      "key": "dba80fee3109c455591dd31eff49c39f1f21727d375a89d5d96f634dfec886938ff41bf17ec2ee664af93ffca293757b0a03c4061c0e70b774722b209a2e5504",
      "line": 382,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "d48ce6fe78c8343547e0ab28b142fe9dfc4d3c0eb06b5ad7789983078b2934a082466ea1adb06cea5b249e186f020a1356d335d44bc518919cc0a623198d5cf2",
      "line": 396,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 27
    },
    {
      "annotations": {
        "Condition": {
          "increasing severity": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "AIBL Research Group.",
          "Ames D",
          "Bush AI",
          "Darby D",
          "Ellis KA",
          "Lim YY",
          "Maruff P",
          "Masters CL",
          "Pietrzak RH",
          "Schembri A",
          "Snyder PJ",
          "Szoeke C"
        ],
        "date": "2013-01-01",
        "first": "Maruff P",
        "last": "Masters CL",
        "name": "BMC psychology",
        "pages": "30",
        "reference": "25566378",
        "title": "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.",
        "type": "PubMed",
        "volume": "1"
      },
      "evidence": "Poorer performance on the memory composite was also associated with worse performance on the Mini Mental State Exam and increasing severity on the Clinical Dementia Rating Scale sum of boxes score.",
      "key": "381a598ff8b43ee26099993d73091298853e15261972e49abaafe6a41a6ff27ac9508366e57cf12823ca3e28599b2be538dc1872d9e60bca63c7de3c69929d4d",
      "line": 410,
      "relation": "negativeCorrelation",
      "source": 4,
      "target": 86
    },
    {
      "annotations": {
        "Anatomy": {
          "anterior cingulate cortex": true,
          "cingulate cortex": true,
          "putamen": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Drzezga A",
          "Förstl H",
          "Grimmer T",
          "Henriksen G",
          "Klunk WE",
          "Kurz A",
          "Mathis CA",
          "Wester HJ"
        ],
        "date": "2009-12-01",
        "first": "Grimmer T",
        "last": "Drzezga A",
        "name": "Neurobiology of aging",
        "pages": "1902-9",
        "reference": "18346821",
        "title": "Clinical severity of Alzheimer's disease is associated with PIB uptake in PET.",
        "type": "PubMed",
        "volume": "30"
      },
      "evidence": "The linear regression analyses showed that the CDR-SOB explained approximately 11-22% of the variance of [11C]PIB uptake. The association attained statistical significance in both frontal, in both anterior cingulate cortices, and in both putamina.",
      "key": "339d4ada7b159bcbf83701f6f17aaa0b5ebb94603fb748f1c0e19538e95752586db775357c51543ee8645a043720417dc89007c852d2c64bab809fb8a4dec60a",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 4,
      "target": 8
    },
    {
      "citation": {
        "authors": [
          "Bharath S",
          "Chandra SR",
          "Huded CB",
          "Sivakumar PT",
          "Subramanian S",
          "Varghese M"
        ],
        "date": "2015-02-01",
        "first": "Huded CB",
        "last": "Subramanian S",
        "name": "Asian journal of psychiatry",
        "pages": "44-7",
        "reference": "25468261",
        "title": "Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.",
        "type": "PubMed",
        "volume": "13"
      },
      "evidence": "The present study was undertaken to validate the measurement of biomarkers as a supplement to the latest diagnostic criteria for Alzheimer disease (AD) dementia by National Institute on Aging-Alzheimer's Association (NIA-AA) work group using a sample attending a tertiary care center in Southern India. A total of 20 subjects diagnosed clinically as Alzheimer's dementia according to the NIA-AA criteria for AD were included in the study. The CSF biomarkers Abeta42, t-tau, and p-tau181 were assessed. The biomarker results were compared among mild and moderate to severe AD as defined in the NIA-AA work group guidelines. The results revealed that the amount of Abeta42 was very low in all the 20 samples (<50pg/ml) collected from mild AD cases with CDR score of 1 (n=8), and moderate to severe AD cases with CDR >1 (n=12). t-tau and p-tau levels were in the range of 39.45+/-5.09pg/ml and 13.06+/-7.32pg/ml for CDR 1 group. t-tau and p-tau levels were in the range of 49.9+/-11.28pg/ml and 33.94+/-15.13pg/ml for moderate to severe cases. Analysis of the data revealed statistically significant differences in the p-tau/t-tau ratio and p-tau/Abeta ratio between CDR 1and CDR >1 AD cases (p<0.001) suggesting that p-tau/t-tau and p-tau/Abeta ratio are good indicators of severity of dementia with discriminative value in differentiating mild AD from moderate to severe AD.",
      "key": "807dbb06502765eeddef08c503bf8e83a4f87568d2d816b0e948757b1f82b5af0de9bd405af5485668aa453eb6b11a974625cb54b72154439927eb73b0f9e8ae",
      "line": 99,
      "relation": "positiveCorrelation",
      "source": 74,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Alexander AL",
          "Asthana S",
          "Bendlin BB",
          "Birdsill AC",
          "Blennow K",
          "Carlsson CM",
          "Johnson SC",
          "Okonkwo OC",
          "Puglielli L",
          "Ries ML",
          "Rowley HA",
          "Sager MA",
          "Sodhi A",
          "Willette AA",
          "Zetterberg H"
        ],
        "date": "2012-01-01",
        "first": "Bendlin BB",
        "last": "Sager MA",
        "name": "PloS one",
        "pages": "e37720",
        "reference": "22701578",
        "title": "CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "7"
      },
      "evidence": "Elevated P-Tau and P-Tau/Aβ42 levels were associated with lower recognition performance on the Rey auditory verbal learning test",
      "key": "7ec4a2fd0ded6c4bdf90f79fa5b0143b64ad81a4232b4b88af6bb349b522deaa4049ca3a8374b02298e8afb333ce54ee5f5f0945898fd7dda2ab7ba1b26ad34a",
      "line": 244,
      "relation": "negativeCorrelation",
      "source": 74,
      "target": 22
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Published": {
          "CDR story": true
        },
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "34378bb00b30721fc32cd277b4ce7895d67e584e41435d9a7ffb3df08913e27c0c53b45fdd4b15d1d27acf4c37db791ecdb917189ec47494e79da685ec2e2d87",
      "line": 281,
      "relation": "negativeCorrelation",
      "source": 74,
      "target": 63
    },
    {
      "key": "c4e71f1866eab20795e7e1d4b54fe09effb8b376e41712f8a130fe5192e07d83b0749cc2e2297b62cbea4bb7b1033909ea6d6423fa06166cb07543cee4249d48",
      "relation": "hasVariant",
      "source": 71,
      "target": 74
    },
    {
      "key": "71d11c842a0d90067081e821cf4f00bb69ca80fd458070ea3b790466eba40d862bf4dbad955b9a492ae093db60d801420fda97521f4a29bff007f33bddf9d118",
      "relation": "hasVariant",
      "source": 71,
      "target": 73
    },
    {
      "key": "baf541cb9323e4b0481d0a275c2c369da942203f26b66675fe3ac5a236e529580f3870d4bbf9c1b0ae336e548a5dcc2b331d6e2e46f10aabc21a35b166eed51c",
      "relation": "hasVariant",
      "source": 71,
      "target": 72
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Published": {
          "CDR story": true
        },
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "cbddc26d2bd7cc08564a806365684aca76a662fe9511807689f3396c93975a3d5e223324b1d9c905072950bf244d5b0c3c67ffe874ab23218445aaa64791b542",
      "line": 280,
      "relation": "negativeCorrelation",
      "source": 71,
      "target": 63
    },
    {
      "key": "55e01cc6e9dd15e0f2a479fdaf8ba2a10e829290b88225e47cfc9d6e11b57f13389576cee8f7426fc5ccf879035acab7c5488c1be3b95500e8c1d9470791e1dd",
      "relation": "hasComponent",
      "source": 29,
      "target": 32
    },
    {
      "key": "ab2ac946925f7bdbcf10a896d30cda8afc15a879d1e8702859c2b81553bf2a4323eeacc5317fc5eaa5c4e57333a4739c207ee11bdf13ec1dec291f8126cddbc3",
      "relation": "hasComponent",
      "source": 29,
      "target": 36
    },
    {
      "citation": {
        "authors": [
          "Alzheimer's Disease Neuroimaging Initiative.",
          "Breitner JC",
          "Corcoran C",
          "Crowley J",
          "Cruchaga C",
          "Goate AM",
          "Green RC",
          "Kauwe JS",
          "Lyketsos C",
          "Munger C",
          "Munger RG",
          "Norton MC",
          "Peterson D",
          "Tschanz J",
          "Welsh-Bohmer KA"
        ],
        "date": "2014-05-01",
        "first": "Peterson D",
        "last": "Kauwe JS",
        "name": "Alzheimer's &amp; dementia : the journal of the Alzheimer's Association",
        "pages": "366-71",
        "reference": "23727081",
        "title": "Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015). ",
      "key": "3b2d84819535a0fb0052de43678a7b1e606595de7cdeec121f89cae51a4dd65a2b8a190aa5e03f5bfbff0ff8a30fcc6f08bf2b647ae733e74e60bfe651d3f150",
      "line": 106,
      "relation": "positiveCorrelation",
      "source": 29,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Alzheimer's Disease Neuroimaging Initiative.",
          "Breitner JC",
          "Corcoran C",
          "Crowley J",
          "Cruchaga C",
          "Goate AM",
          "Green RC",
          "Kauwe JS",
          "Lyketsos C",
          "Munger C",
          "Munger RG",
          "Norton MC",
          "Peterson D",
          "Tschanz J",
          "Welsh-Bohmer KA"
        ],
        "date": "2014-05-01",
        "first": "Peterson D",
        "last": "Kauwe JS",
        "name": "Alzheimer's &amp; dementia : the journal of the Alzheimer's Association",
        "pages": "366-71",
        "reference": "23727081",
        "title": "Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015). ",
      "key": "62e0961c0468031391c12040f145073626568cf0117a0ddbe0f0c5275393190ea4a8995f5ce8c3c5da6f32f57b362c6da84f6ebf7fd0326cba1eb9a015936c73",
      "line": 107,
      "relation": "causesNoChange",
      "source": 32,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Alzheimer's Disease Neuroimaging Initiative.",
          "Breitner JC",
          "Corcoran C",
          "Crowley J",
          "Cruchaga C",
          "Goate AM",
          "Green RC",
          "Kauwe JS",
          "Lyketsos C",
          "Munger C",
          "Munger RG",
          "Norton MC",
          "Peterson D",
          "Tschanz J",
          "Welsh-Bohmer KA"
        ],
        "date": "2014-05-01",
        "first": "Peterson D",
        "last": "Kauwe JS",
        "name": "Alzheimer's &amp; dementia : the journal of the Alzheimer's Association",
        "pages": "366-71",
        "reference": "23727081",
        "title": "Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression Study.",
        "type": "PubMed",
        "volume": "10"
      },
      "evidence": "Although we observed no association between rs3785883 or rs1868402 alone and change in CDR-sb (P > .10), there was a significant association between a combined genotype model and change in CDR-sb: carriers of the high-risk genotypes at both loci progressed >2.9 times faster than noncarriers (P = .015). ",
      "key": "bebae3f89815f2fecfd8b0bbd4fded604628643de1c5f14d3d07d1ee73756f9215c49ffd0bebb741f656b39bab7a21b4b73215fa52bcb67f7de3b68de4425c79",
      "line": 108,
      "relation": "causesNoChange",
      "source": 36,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "hippocampus cortex cingulum": true
        }
      },
      "citation": {
        "authors": [
          "Choi W",
          "Kang K",
          "Lee HW",
          "Yoon U"
        ],
        "date": "2016-05-15",
        "first": "Kang K",
        "last": "Lee HW",
        "name": "Journal of the neurological sciences",
        "pages": "90-6",
        "reference": "27084223",
        "title": "Diffusion tensor imaging of idiopathic normal-pressure hydrocephalus and the cerebrospinal fluid tap test.",
        "type": "PubMed",
        "volume": "364"
      },
      "evidence": "In the right left cingulum-hippocampus (CgH), FA (Fractional anisotropy) values showed significant positive correlations with Korean-Mini Mental State Examination scores and negative correlations with Clinical Dementia Rating Scale scores.",
      "key": "4529faf856f3b7460ddadc65790e4cf793a3c0329debfe024af972eb3d8dee4988bcdfd2afde4a023a155eaac03403b7861929fb06defb647ba7c5fc001c248d",
      "line": 118,
      "relation": "negativeCorrelation",
      "source": 16,
      "target": 14
    },
    {
      "annotations": {
        "Anatomy": {
          "hippocampus cortex cingulum": true
        }
      },
      "citation": {
        "authors": [
          "Choi W",
          "Kang K",
          "Lee HW",
          "Yoon U"
        ],
        "date": "2016-05-15",
        "first": "Kang K",
        "last": "Lee HW",
        "name": "Journal of the neurological sciences",
        "pages": "90-6",
        "reference": "27084223",
        "title": "Diffusion tensor imaging of idiopathic normal-pressure hydrocephalus and the cerebrospinal fluid tap test.",
        "type": "PubMed",
        "volume": "364"
      },
      "evidence": "In the right left cingulum-hippocampus (CgH), FA (Fractional anisotropy) values showed significant positive correlations with Korean-Mini Mental State Examination scores and negative correlations with Clinical Dementia Rating Scale scores.",
      "key": "05c91306a4cba85dbfccff21d9bf2c905f9db52e3bec9773d800dca290b2c88a776785f8ceba85b22c5ef3967eb7f4b2d3cc890fe76d5e51b760cf25fa7ccb69",
      "line": 118,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 16
    },
    {
      "citation": {
        "authors": [
          "Hirneiß C",
          "Kampik A",
          "Lamparter J",
          "Reznicek L",
          "Vogel M"
        ],
        "date": "2015-07-01",
        "first": "Reznicek L",
        "last": "Hirneiß C",
        "name": "Current eye research",
        "pages": "683-9",
        "reference": "25207744",
        "title": "Flicker defined form perimetry in glaucoma suspects with normal achromatic visual fields.",
        "type": "PubMed",
        "volume": "40"
      },
      "evidence": "The Heidelberg Retina Tomograph (HRT). assessed CDR was significantly correlated with the MD in HEP (Heidelberg Edge Perimetry, HEP)  II (r = -0.281, p = 0.04). In HEP I, VF defects on CPA testing were found in 38 study eyes (58.5%).",
      "key": "73a97b44e562dfcc5c6c0bf5af8da9a971b236153dd88821fb2e0883810469efb08885a222d71a8c551abdd3de9467d0562c9ff80d7cdcd500a53f8a28b879dd",
      "line": 138,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 17
    },
    {
      "citation": {
        "authors": [
          "Fischer CE",
          "Ismail Z",
          "Lix LM",
          "Millikin CP",
          "Munoz DG",
          "Qian W",
          "Schweizer TA",
          "Shelton P",
          "Smith EE"
        ],
        "date": "2016-01-01",
        "first": "Fischer CE",
        "last": "Munoz DG",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "283-95",
        "reference": "26682680",
        "title": "Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.",
        "type": "PubMed",
        "volume": "50"
      },
      "evidence": "Hallucinations were associated with greater cognitive and functional impairments on the MMSE and CDR, while delusional patients showed less impairment on CDR, consistent across cAD and npAD groups.",
      "key": "133d16f72fb5e2af93b9528a3b0d95b382d344ad39a2360249d1fb66d9e8d174d26b8a595d14c2929353ebd326fdcbc427a89e9cdabed11b43d2913c7bfc65b1",
      "line": 173,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 87
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Subgraph": {
          "Plasminogen activator subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Kim H",
          "Lee HJ",
          "Oh J",
          "Park SI",
          "Song JH"
        ],
        "date": "2014-12-01",
        "first": "Oh J",
        "last": "Kim H",
        "name": "Experimental gerontology",
        "pages": "87-91",
        "reference": "25304332",
        "title": "Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "60"
      },
      "evidence": "Our results show that plasma PAI-1 levels gradually increased as dementia progressed. The mean levels of plasma PAI-1 in patients with MCI and AD patients were significantly higher than those of in healthy controls. Consistently, neuropsychological examination (e.g., MMSE, CDR) also demonstrated significant correlations between the plasma PAI-1 levels and cognitive function. ",
      "key": "5aaf431e078aef3a43e143ef6a85a548b845424f0af8aeb5c9b3fe99ab8e6063b47b4480606c899ce339aee636ff5f45fb1fce4d42e5cb367846598eb14b11ed",
      "line": 188,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 79
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "3b7f80d9f52f7e6d09ae7f0672e5dd867b4dd320a5276c10105aa99d3864159154ad135194d995a5478a39626975e476a7e0a2fa559a3a9d5b6dd01aef94362e",
      "line": 223,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 39
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "760ce3939b1bb8cfb1d6beba59ffc3cc2b3af44712c0339ee82c69dd9098886f122b5dcc262e3e77db09eda1871843a6781a9de47c71b929b95e6e0fdb4a3932",
      "line": 224,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 34
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "26787122ba4cbae227b81e3041fcfbcdfb42a00ff6f827a6ba04e3efbf04bc317f23f09ff5b74e0c295d2ba907f713078162d9e663c40003c81bb79637bda394",
      "line": 225,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 45
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "51b78b8b1390709778edd117dd23af10889ee32a208cf9b349e7434f3f2dbb613f5ed58483b94b7fc5b8a790cfb24283039703d57e24f9cba690e165568bc4df",
      "line": 226,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 47
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "b9cc56605a93f820c510e9cdc38afde6afd9c4470672c32b1b51dab1e34a37172268a4cc60c74c0efe24b615514f2a15cb9257405a945442eeec08b4824a273d",
      "line": 227,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 31
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "88dc38bc4aab28a4cdca85ef73cc5a6401c6b25f5014f63d4e5515ae1e90c3bad87ccfdb044e7a6142d55905ec207edc4602d4a426780c4f3f0a678ca4ae7602",
      "line": 228,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 33
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "ab7d73940365651a26dcc0fd4d4c87be9ba5386052829e9323e9eeb6e88d5ea91e675a77dc7b35a5c8711ee0cd124ee9302172029bb081c868fb8b51a461996b",
      "line": 229,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 44
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "1470af01dc409affef39142c6669a3f622422f636566ac4d8fc56f59469df35126527f7575cd759dff6764657191bfce76b2911d23097a2f5e9678ae5ef029e4",
      "line": 230,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 46
    },
    {
      "citation": {
        "authors": [
          "Blanco A",
          "Coen RF",
          "Lawlor BA",
          "Lynch CA",
          "Moran M",
          "Walsh C",
          "Walsh JB"
        ],
        "date": "2006-01-01",
        "first": "Lynch CA",
        "last": "Lawlor BA",
        "name": "Dementia and geriatric cognitive disorders",
        "pages": "40-3",
        "reference": "16254429",
        "title": "The clinical dementia rating sum of box score in mild dementia.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "The Clinical Dementia Rating (CDR) scale is a widely used dementia staging instrument, yielding a global score and a summated score (sum of box score). ",
      "key": "790e627a0b715bce47940b3e6956200b7a9a012f962848599d6a9dfeccae3cc3a8a50df615846f0b228b9730c75f796e6cbdf2447013af2fe37a3e7ddc0076c8",
      "line": 238,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 4
    },
    {
      "annotations": {
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "57f6a032f64aae2e0b8f8f764c31ed86f1db03b8236f735a6b8ec8474b8cb2324c6de4ba23d61b7733a1fac65d86d16204790b86f0de5fe3b6422ce2a63471e9",
      "line": 273,
      "relation": "negativeCorrelation",
      "source": 14,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Chen Z",
          "Chui D",
          "Fan D",
          "Guo X",
          "Kong F",
          "Tabira T",
          "Tian X",
          "Tong Y",
          "Wang H",
          "Xiao W",
          "Yang H",
          "Yu J",
          "Zhang S",
          "Zhang T",
          "Zhou T"
        ],
        "date": "2014-01-01",
        "first": "Tong Y",
        "last": "Chui D",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "865-78",
        "reference": "24961945",
        "title": "High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.",
        "type": "PubMed",
        "volume": "42"
      },
      "evidence": "In the study, we recruited 40 Chinese elders with different cognitive statuses and investigated concentrations of Mn in whole blood and plasma amyloid-β (Aβ) peptides. Surprisingly, there were significant correlations of Mn with Mini-Mental State Examination score and Clinical Dementia Rating Scale score. In addition, plasma Aβ peptides increased with elevated Mn. ",
      "key": "0472d45774a4261d9d6311bcad31985028d25cf10b35418fa46cd2078e6d6c7e2fd17c3c2a369cb240b8fa8db9e27b808ac9996ab02adce30e5f9f2410ce2f17",
      "line": 296,
      "relation": "positiveCorrelation",
      "source": 14,
      "target": 1
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Subgraph": {
          "MAPK-ERK subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Crimmins D",
          "D'Angelo G",
          "Fagan AM",
          "Griest T",
          "Herries E",
          "Holtzman DM",
          "Ladenson JH",
          "Morris JC",
          "Tarawneh R",
          "Zipfel GJ"
        ],
        "date": "2016-05-01",
        "first": "Tarawneh R",
        "last": "Holtzman DM",
        "name": "JAMA neurology",
        "pages": "561-71",
        "reference": "27018940",
        "title": "Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.",
        "type": "PubMed",
        "volume": "73"
      },
      "evidence": "The CSF neurogranin levels correlated with brain atrophy (normalized whole-brain volumes: adjusted r = -0.38, P = .02; hippocampal volumes: adjusted r = -0.36, P = .03; entorhinal volumes: adjusted r = -0.46, P = .006; and parahippocampal volumes: adjusted r = -0.47, P = .005, n = 38) in AD and with amyloid load (r = 0.39, P = .02, n = 36) in preclinical AD.",
      "key": "c01c0e3245880e46bd1683c8d364ce80ae7ef2568fcb94eab3774a91f84fe615c5f0657761fd87d952ca2f1ed29b08459505ae3a30382bdf736f28e3b8a35894",
      "line": 130,
      "relation": "positiveCorrelation",
      "source": 77,
      "target": 13
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Subgraph": {
          "MAPK-ERK subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Crimmins D",
          "D'Angelo G",
          "Fagan AM",
          "Griest T",
          "Herries E",
          "Holtzman DM",
          "Ladenson JH",
          "Morris JC",
          "Tarawneh R",
          "Zipfel GJ"
        ],
        "date": "2016-05-01",
        "first": "Tarawneh R",
        "last": "Holtzman DM",
        "name": "JAMA neurology",
        "pages": "561-71",
        "reference": "27018940",
        "title": "Diagnostic and Prognostic Utility of the Synaptic Marker Neurogranin in Alzheimer Disease.",
        "type": "PubMed",
        "volume": "73"
      },
      "evidence": "The CSF neurogranin levels correlated with brain atrophy (normalized whole-brain volumes: adjusted r = -0.38, P = .02; hippocampal volumes: adjusted r = -0.36, P = .03; entorhinal volumes: adjusted r = -0.46, P = .006; and parahippocampal volumes: adjusted r = -0.47, P = .005, n = 38) in AD and with amyloid load (r = 0.39, P = .02, n = 36) in preclinical AD.",
      "key": "1c277068d147dc6e1f27b0ef91717f5369baeba25b5cb311978a1813ba51aae1282efd201f8494a4d2ad1dd90ca5097d677338d78521f05104c9fd614e7421be",
      "line": 130,
      "relation": "positiveCorrelation",
      "source": 13,
      "target": 77
    },
    {
      "key": "344d517a64d87315201abc7f8c81be638841e63398d0303e79e3bfae11b46b40b528837c1f20cb1c0329e03ab92aeddc7efbb16a2f403badf448f6ed834c03bb",
      "relation": "hasComponent",
      "source": 28,
      "target": 70
    },
    {
      "key": "88cee7e543444d00a2f0e51e9471d3c39780184c07e5d35e247ae84b04cff0b16b6e74ea18997b7285f8d276da241ea724b616c469f875a4eca377aa2979f072",
      "relation": "hasComponent",
      "source": 28,
      "target": 77
    },
    {
      "citation": {
        "authors": [
          "Hirneiß C",
          "Kampik A",
          "Lamparter J",
          "Reznicek L",
          "Vogel M"
        ],
        "date": "2015-07-01",
        "first": "Reznicek L",
        "last": "Hirneiß C",
        "name": "Current eye research",
        "pages": "683-9",
        "reference": "25207744",
        "title": "Flicker defined form perimetry in glaucoma suspects with normal achromatic visual fields.",
        "type": "PubMed",
        "volume": "40"
      },
      "evidence": "The Heidelberg Retina Tomograph (HRT). assessed CDR was significantly correlated with the MD in HEP (Heidelberg Edge Perimetry, HEP)  II (r = -0.281, p = 0.04). In HEP I, VF defects on CPA testing were found in 38 study eyes (58.5%).",
      "key": "5834f9a91ef4af8e80b1d65e83d72f4eb6103dc4ecabb0a6edd5a7fbe3db75121f14aa8bdc9148887ac0e294753ec33cd1663a2079cbbcc8f35c2322b604b98f",
      "line": 138,
      "relation": "positiveCorrelation",
      "source": 17,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Brix S",
          "Christiansen C",
          "Dragsbæk K",
          "Henriksen K",
          "Karsdal MA",
          "Neergaard JS",
          "Nielsen HB",
          "Workman CT"
        ],
        "date": "2017-09-01",
        "first": "Neergaard JS",
        "last": "Karsdal MA",
        "name": "Neurochemistry international",
        "pages": "303-308",
        "reference": "28499950",
        "title": "Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum.",
        "type": "PubMed",
        "volume": "108"
      },
      "evidence": "Our research group has developed two solid phase competitive ELISA assays detecting proteolytic fragments of tau in serum. One assay detects the caspase-generated fragment cleaved at Asp421 (Tau-C) and the other measures an ADAM10-generated fragment cleaved at Ala152 (Tau-A) of tau.",
      "key": "01ae654df209907a02a220b702f4f04b8051f0b1149338ffa6cc7f1ea801214c6ec0339e32fa07ad38b5856be9848110102ab2abe13f3c444d8ffbabbcd2c002",
      "line": 148,
      "relation": "directlyIncreases",
      "source": 54,
      "subject": {
        "modifier": "Activity"
      },
      "target": 92
    },
    {
      "key": "1b264ea098cbce593c028854ee3c1365fa95e9146e33db069cd2cfef050cf0ca76264708f0b6891a9017e4ef9fb0b59a6df8514c18a6a3d0b2fba258a78f9828",
      "relation": "hasReactant",
      "source": 92,
      "target": 71
    },
    {
      "key": "f18c65b1f4f20edd84dcf7893589aaad09e4a1041f467ac8889bb86a8f9b0fcd234414ba0400d7dc9c866ad45edd9d216a8aa59cc554151910cfb03c7dd5cc9f",
      "relation": "hasProduct",
      "source": 92,
      "target": 73
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "a75662bc4c8ec0b3dcd14e9a9f6e762c717d9c21d1a69c57c305dee1be2b53e59ad6f4c6835243a574d633f28581c2313e46f591655c1f90f99c79e834675f98",
      "line": 160,
      "relation": "causesNoChange",
      "source": 73,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "3fce3c916748579204d97eda1715d8b3d6dfdc4e456f69b5ceb648b19011a2931eadac3ba79d5f52f59c26cd4266c2272787431fa427dc49f04c3a06e7744009",
      "line": 163,
      "relation": "causesNoChange",
      "source": 73,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "f2adc7be63c5cc27bbe5a6f65a1ff9fe281b33962c880f582cc7e47e3b6a8fdb8c074d1069f376d31aee1121abbef25a2be5b4370460965607f4f35b6c1f587b",
      "line": 166,
      "relation": "causesNoChange",
      "source": 73,
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Brix S",
          "Christiansen C",
          "Dragsbæk K",
          "Henriksen K",
          "Karsdal MA",
          "Neergaard JS",
          "Nielsen HB",
          "Workman CT"
        ],
        "date": "2017-09-01",
        "first": "Neergaard JS",
        "last": "Karsdal MA",
        "name": "Neurochemistry international",
        "pages": "303-308",
        "reference": "28499950",
        "title": "Modifiable risk factors promoting neurodegeneration is associated with two novel brain degradation markers measured in serum.",
        "type": "PubMed",
        "volume": "108"
      },
      "evidence": "Our research group has developed two solid phase competitive ELISA assays detecting proteolytic fragments of tau in serum. One assay detects the caspase-generated fragment cleaved at Asp421 (Tau-C) and the other measures an ADAM10-generated fragment cleaved at Ala152 (Tau-A) of tau.",
      "key": "cd08c8cb5b28c37bbb4fb9371407eb200f13b5928736111b22c1c235d787af17df7c0e556f796bd5ee645ca6e36c45a4aa387f55235c1f8677ff5b0eafad501d",
      "line": 149,
      "relation": "directlyIncreases",
      "source": 61,
      "subject": {
        "modifier": "Activity"
      },
      "target": 91
    },
    {
      "key": "5f9cdbc6aa96c2a738a58c3a6618b4cdaf314f81401b8b95dcd00559ab59bb096b9954a393d678906d9b1e16e14af04f26ab17f2967a1dd3e370bb6f03884185",
      "relation": "hasReactant",
      "source": 91,
      "target": 71
    },
    {
      "key": "c1fefe7630515a2b5568f40011779fb215512bfe05e22ee699d02f8471438f49c33b02019339263c7e1581b68aa62637e071610a79c7f4bea1b6d402a3ca0b5b",
      "relation": "hasProduct",
      "source": 91,
      "target": 72
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "5ec17ae053da0f7f10df958cfcf2651dffd87245e4b378767de690aa42150655d873d4e952295806abc3d7a7a18170940e684b0b69051d543fb8ac256cd4080e",
      "line": 159,
      "relation": "causesNoChange",
      "source": 72,
      "target": 4
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "6a854437139e1adae8484f946275b6a66a88d6220dd1e9755068cba2c0909e3caacab084fcf7dc1d94b00d7717f00a7b2312469d03408d39811b9681c3be2cec",
      "line": 162,
      "relation": "causesNoChange",
      "source": 72,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Byrjalsen I",
          "Christiansen C",
          "Henriksen K",
          "Karsdal MA"
        ],
        "date": "2015-01-01",
        "first": "Henriksen K",
        "last": "Karsdal MA",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "1331-41",
        "reference": "25171717",
        "title": "Relationship between serum levels of tau fragments and clinical progression of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "43"
      },
      "evidence": "We did not find any significant relationship to baseline ADAS-Cog11, CDR-SB, or MMSE for either Tau-A, Tau-C, or the ratio between these, a finding which indicates that these markers do not have diagnostic potential in this population of putative early AD patients, which is somewhat different from the relationship between Tau-A and MDRS score previously observed in a small study of late stage AD",
      "key": "eeb2a215cc758c617a0b4f9d4b8d23148db7b53233ec0850dbf756bfd55a8eda60f2b41dd945719fbb59bfb2373ae18cd47137861cdbc3233add51aba433e9e7",
      "line": 165,
      "relation": "causesNoChange",
      "source": 72,
      "target": 12
    },
    {
      "citation": {
        "authors": [
          "Fischer CE",
          "Ismail Z",
          "Lix LM",
          "Millikin CP",
          "Munoz DG",
          "Qian W",
          "Schweizer TA",
          "Shelton P",
          "Smith EE"
        ],
        "date": "2016-01-01",
        "first": "Fischer CE",
        "last": "Munoz DG",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "283-95",
        "reference": "26682680",
        "title": "Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.",
        "type": "PubMed",
        "volume": "50"
      },
      "evidence": "Hallucinations were associated with greater cognitive and functional impairments on the MMSE and CDR, while delusional patients showed less impairment on CDR, consistent across cAD and npAD groups.",
      "key": "2c74b87e6edeaf913d333c408cae198c51b974453057f725d7aa44b73b604af1911fc233224481fbf624e82f5409118accd51e5d86164fe5ad724fe3fda46053",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 87
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Subgraph": {
          "Plasminogen activator subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Kim H",
          "Lee HJ",
          "Oh J",
          "Park SI",
          "Song JH"
        ],
        "date": "2014-12-01",
        "first": "Oh J",
        "last": "Kim H",
        "name": "Experimental gerontology",
        "pages": "87-91",
        "reference": "25304332",
        "title": "Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "60"
      },
      "evidence": "Our results show that plasma PAI-1 levels gradually increased as dementia progressed. The mean levels of plasma PAI-1 in patients with MCI and AD patients were significantly higher than those of in healthy controls. Consistently, neuropsychological examination (e.g., MMSE, CDR) also demonstrated significant correlations between the plasma PAI-1 levels and cognitive function. ",
      "key": "d82c87b03eb01a225c04cfd1085d86245ee088af090e04173076a376f7766f969c0b332357a645142c8f6d2364822b04e4cecb1fae312a7f4989257ae27af2e5",
      "line": 189,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 79
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Chen Z",
          "Chui D",
          "Fan D",
          "Guo X",
          "Kong F",
          "Tabira T",
          "Tian X",
          "Tong Y",
          "Wang H",
          "Xiao W",
          "Yang H",
          "Yu J",
          "Zhang S",
          "Zhang T",
          "Zhou T"
        ],
        "date": "2014-01-01",
        "first": "Tong Y",
        "last": "Chui D",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "865-78",
        "reference": "24961945",
        "title": "High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.",
        "type": "PubMed",
        "volume": "42"
      },
      "evidence": "In the study, we recruited 40 Chinese elders with different cognitive statuses and investigated concentrations of Mn in whole blood and plasma amyloid-β (Aβ) peptides. Surprisingly, there were significant correlations of Mn with Mini-Mental State Examination score and Clinical Dementia Rating Scale score. In addition, plasma Aβ peptides increased with elevated Mn. ",
      "key": "bf19c176931918113e19317098fba0dd2379e79ece8d8c84b5885488980bc86136a3b6cecb0481982f87ba9d955a5f29a84a16763f9d0fb5b2799dbea0114cf7",
      "line": 295,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 1
    },
    {
      "annotations": {
        "Anatomy": {
          "urine": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Among these three markers, the lower 3-HPMA/Cre ratio was most strongly correlated with the decline of MMSE (Mini-Mental State Examination) and the increase in CDRsob (Clinical Dementia Rating Scale Sum of Boxes Scores).",
      "key": "7147bb5298d2c6e1b7b1cadca3cb8a70e4b87b080b46df5a1b2d211da3821238bf5ab41adb8a7a0f9e891c1468b538a09a437adc6d028c3507d29c46136a641f",
      "line": 348,
      "relation": "negativeCorrelation",
      "source": 20,
      "target": 9
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "6813ec461b1cb452a0d4701affc1b4c95d022859cea85ba553290e3349c167f9f9b2bf5b0825862f970ddc890125ac86eb367772f8337af0c9a082c69c378b27",
      "line": 397,
      "relation": "negativeCorrelation",
      "source": 20,
      "target": 27
    },
    {
      "annotations": {
        "Condition": {
          "increasing severity": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "AIBL Research Group.",
          "Ames D",
          "Bush AI",
          "Darby D",
          "Ellis KA",
          "Lim YY",
          "Maruff P",
          "Masters CL",
          "Pietrzak RH",
          "Schembri A",
          "Snyder PJ",
          "Szoeke C"
        ],
        "date": "2013-01-01",
        "first": "Maruff P",
        "last": "Masters CL",
        "name": "BMC psychology",
        "pages": "30",
        "reference": "25566378",
        "title": "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.",
        "type": "PubMed",
        "volume": "1"
      },
      "evidence": "Poorer performance on the memory composite was also associated with worse performance on the Mini Mental State Exam and increasing severity on the Clinical Dementia Rating Scale sum of boxes score.",
      "key": "7050530380befc62bb715ee62c7bce7f593673296f349a33503835696072ed3506cc11836431cb80f8613b97fa552981167fc4f3340258ae4916b136267b7c37",
      "line": 409,
      "relation": "positiveCorrelation",
      "source": 20,
      "target": 86
    },
    {
      "citation": {
        "authors": [
          "Fischer CE",
          "Ismail Z",
          "Lix LM",
          "Millikin CP",
          "Munoz DG",
          "Qian W",
          "Schweizer TA",
          "Shelton P",
          "Smith EE"
        ],
        "date": "2016-01-01",
        "first": "Fischer CE",
        "last": "Munoz DG",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "283-95",
        "reference": "26682680",
        "title": "Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.",
        "type": "PubMed",
        "volume": "50"
      },
      "evidence": "Hallucinations were associated with greater cognitive and functional impairments on the MMSE and CDR, while delusional patients showed less impairment on CDR, consistent across cAD and npAD groups.",
      "key": "8bc6131068e3eee2f8ac0846e82bf6d90dce1ff2efd9eb7478cb5ebb58ef14f95eb7bce1bd1a4a94766c88e27a5a980a46620f8a4da6d4830bc02e12bca55a06",
      "line": 173,
      "relation": "positiveCorrelation",
      "source": 87,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fischer CE",
          "Ismail Z",
          "Lix LM",
          "Millikin CP",
          "Munoz DG",
          "Qian W",
          "Schweizer TA",
          "Shelton P",
          "Smith EE"
        ],
        "date": "2016-01-01",
        "first": "Fischer CE",
        "last": "Munoz DG",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "283-95",
        "reference": "26682680",
        "title": "Lewy Bodies, Vascular Risk Factors, and Subcortical Arteriosclerotic Leukoencephalopathy, but not Alzheimer Pathology, are Associated with Development of Psychosis in Alzheimer's Disease.",
        "type": "PubMed",
        "volume": "50"
      },
      "evidence": "Hallucinations were associated with greater cognitive and functional impairments on the MMSE and CDR, while delusional patients showed less impairment on CDR, consistent across cAD and npAD groups.",
      "key": "27196fedee03573ff7282afb9d203af118bc9eccb4d4588051c370448ce9218b41a28bd851785de14a8eca53fb8213a4c10fa62064d9c404a829b5de3665ff4a",
      "line": 174,
      "relation": "positiveCorrelation",
      "source": 87,
      "target": 20
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Subgraph": {
          "Plasminogen activator subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Kim H",
          "Lee HJ",
          "Oh J",
          "Park SI",
          "Song JH"
        ],
        "date": "2014-12-01",
        "first": "Oh J",
        "last": "Kim H",
        "name": "Experimental gerontology",
        "pages": "87-91",
        "reference": "25304332",
        "title": "Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "60"
      },
      "evidence": "Our results show that plasma PAI-1 levels gradually increased as dementia progressed. The mean levels of plasma PAI-1 in patients with MCI and AD patients were significantly higher than those of in healthy controls. Consistently, neuropsychological examination (e.g., MMSE, CDR) also demonstrated significant correlations between the plasma PAI-1 levels and cognitive function. ",
      "key": "cf17ffdb3f85041a79c0b630d4e55ab8f4389f65f6272cd1a51f61991eecb4f43981c550e074078d6251c82d0817cf784fb15e17adcdaf85367c214f79aed873",
      "line": 188,
      "relation": "positiveCorrelation",
      "source": 79,
      "target": 14
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Plasma": true
        },
        "Subgraph": {
          "Plasminogen activator subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Kim H",
          "Lee HJ",
          "Oh J",
          "Park SI",
          "Song JH"
        ],
        "date": "2014-12-01",
        "first": "Oh J",
        "last": "Kim H",
        "name": "Experimental gerontology",
        "pages": "87-91",
        "reference": "25304332",
        "title": "Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "60"
      },
      "evidence": "Our results show that plasma PAI-1 levels gradually increased as dementia progressed. The mean levels of plasma PAI-1 in patients with MCI and AD patients were significantly higher than those of in healthy controls. Consistently, neuropsychological examination (e.g., MMSE, CDR) also demonstrated significant correlations between the plasma PAI-1 levels and cognitive function. ",
      "key": "2ded2cb343930afcca9cc42ad645857e249744a6b9f75729bc189fdafd2c38f9f42587fee9be1fc70b35cb7f43d931e54dec956ba5dc6c1526644ec88a5b80c1",
      "line": 189,
      "relation": "positiveCorrelation",
      "source": 79,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Belden CM",
          "Davis K",
          "Malek-Ahmadi M",
          "Sabbagh MN"
        ],
        "date": "2014-07-01",
        "first": "Malek-Ahmadi M",
        "last": "Sabbagh MN",
        "name": "Alzheimer disease and associated disorders",
        "pages": "296-8",
        "reference": "23138174",
        "title": "Comparative analysis of the Alzheimer questionnaire (AQ) with the CDR sum of boxes, MoCA, and MMSE.",
        "type": "PubMed",
        "volume": "28"
      },
      "evidence": "The Alzheimer Questionnaire (AQ) correlated strongly with the CDR Sum of Boxes (r=0.79) and demonstrated similar diagnostic accuracy with the MoCA and MMSE. These results suggest that the AQ is comparable with other established informant-based and patient-based measures. ",
      "key": "ec80881250819d7cfd16b61c3deaa5c0dacd73a4aa54d74d9afc8cbec5ffb1c4e05397f20e4b5cc4e8042cde47b9ac25dfedf072bad1f05186944ebd63ab0d4f",
      "line": 202,
      "relation": "positiveCorrelation",
      "source": 11,
      "target": 4
    },
    {
      "key": "2548e504e3ff1760e56d18cb59987a0a28852808589fee8f5e45cfa7037a9cabf4659e28604ecba5ac22ac3ce5bcae83bdfa99fb742d8bf4a1d8475fa8457148",
      "relation": "hasVariant",
      "source": 65,
      "target": 39
    },
    {
      "key": "9a96b6a37cef20a21bc0b3f6b99f56092bdc99134072dfa3280664501aec448d01919154145599a71b53e109bf6ed5b224bfea5e331ad8dd675c346f05064efd",
      "relation": "hasVariant",
      "source": 65,
      "target": 34
    },
    {
      "key": "8f808083b3dd3dad053f9fc91391026ce06dfa762612c12d67aa95118917e22bc860c9773287099bd180ac4a6e2a42676be6beb4abfe1c8ba727b5849e2761ab",
      "relation": "hasVariant",
      "source": 65,
      "target": 45
    },
    {
      "key": "8b84f63cc373e428d26d22333430aba88d2f367d4808a270a951b44d80ef0cf5b6e7f8642fcd1405f8a06375aa7579ffa17bdcf1387942b3303bf2803192b6f2",
      "relation": "hasVariant",
      "source": 65,
      "target": 47
    },
    {
      "key": "cc845d855a29541093d69873b40ca444779ca93477ce8b4057b2a954e037e70091f32929d4b34363720f433927662efb15850cf0543c2653b2850b90dfd3be02",
      "relation": "hasVariant",
      "source": 65,
      "target": 31
    },
    {
      "key": "31b3880cef257e2f5f80b68cd0113f3c38e46fffeee4f40525179ea185a3fd46136da07e59cf188b91b618e7305bb779b225b6c94093085618068f1f66ea650d",
      "relation": "hasVariant",
      "source": 65,
      "target": 33
    },
    {
      "key": "443dea957ad1dc2f6b52915673f2d8393f692336744848a4d48ef8cafd14cf162e7a4ad22a35ebdf5a30a903a606da92ac3c7d1ea3604f6a05275ddb677a0115",
      "relation": "hasVariant",
      "source": 65,
      "target": 44
    },
    {
      "key": "d75cf3de474f6e26bbb47c3618878121d219e9560c0d6a6d0b7cc84116fc6c756d396e8820818fc1e64b15a45f9d4b651147524d9d7d74898bf34f530a304fdc",
      "relation": "hasVariant",
      "source": 65,
      "target": 46
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "5697d17ed05bcaa0a73aae7cfd1ca51e04087542280cbd991cd2b1eb42263243a14b5ffdf6a1fb0c1ecf6af011d9dd92d54919aecb3b49088c2c91f105652bfa",
      "line": 223,
      "relation": "positiveCorrelation",
      "source": 39,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "db1c94b3cbbb0d2001a0b2a1d69f2401325a2da5a253ef44c10820497fa2e0bd4cc1f100c580d3fdbfa73d31f49a39e3b55d4957cd5c4983c058d17032660bdd",
      "line": 224,
      "relation": "positiveCorrelation",
      "source": 34,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "4a5fbb3a1db5fc14e47e1989c0835ee9ef140fd46c060f95a3e4679555943e77067fc4ab595033aa86c4a28858a76ef44061281e9083f57bb8c5814c3d0ca07b",
      "line": 225,
      "relation": "positiveCorrelation",
      "source": 45,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "1c3e10a2d73b260bdcf16031a8976924431b8a3bd38ba651d7d92befd3cee5264e908c323be3e396fbe9eb2f10cabdd4d249bb6dedcbec2a16e45fb29e557f0d",
      "line": 226,
      "relation": "positiveCorrelation",
      "source": 47,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "4dbeb845c872c29cd719c47836f603879e4d8c3848f1aa1ef8edf852f95f37bfb32dd887b13bf12035e31bd723b325b5ab8349b5d2e534831fa6065efefe5505",
      "line": 227,
      "relation": "positiveCorrelation",
      "source": 31,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "31d7ed0a400b2565dfeaee68a7a876f6010dcd119af738eda0e2faa016363f94a376b203cc8f8410d555f97bf4bcc3aa971f77f7e19bfac45b1c9a246f850dbb",
      "line": 228,
      "relation": "positiveCorrelation",
      "source": 33,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "0cb0be3e577ef59974e48993b5de37f5cf70c17371b50ed75ad8a021f0131eb252228003f80210bac8cbab034d4e864cd4b7b21a9bb2140aa94396fcb17f3f4c",
      "line": 229,
      "relation": "positiveCorrelation",
      "source": 44,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Fung AW",
          "Lam LC",
          "Leung GT",
          "Ma SL",
          "Tang NL"
        ],
        "date": "2014-05-01",
        "first": "Ma SL",
        "last": "Lam LC",
        "name": "The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry",
        "pages": "489-98",
        "reference": "23567436",
        "title": "Estrogen receptor α polymorphisms and the risk of cognitive decline: A 2-year follow-up study.",
        "type": "PubMed",
        "volume": "22"
      },
      "evidence": "Different sets of ESR1 polymorphisms were associated with cognitive decline from CDR 0 to 0.5 and CDR 0.5 to 1. ESR1 polymorphisms (rs3853248, rs22334693 [ESR1+397], rs9340799 [ESR1+351], rs9397456, rs1801132 [ESR1+975], rs2179922, rs932477, and rs9341016) were associated with the deterioration of episodic memory among subjects with baseline CDR 0, indicating these polymorphisms might be markers for episodic memory decline at an earlier stage.",
      "key": "e6cdc51a2bd1b0d19b6f2c27aa7ceb77a65e9f2338c70ab677a4bff6ecffb60282d8b8364a5a21e8306fdc70484c437f9923c9451702f912ce6524eea5eadc2f",
      "line": 230,
      "relation": "positiveCorrelation",
      "source": 46,
      "target": 14
    },
    {
      "citation": {
        "authors": [
          "Alexander AL",
          "Asthana S",
          "Bendlin BB",
          "Birdsill AC",
          "Blennow K",
          "Carlsson CM",
          "Johnson SC",
          "Okonkwo OC",
          "Puglielli L",
          "Ries ML",
          "Rowley HA",
          "Sager MA",
          "Sodhi A",
          "Willette AA",
          "Zetterberg H"
        ],
        "date": "2012-01-01",
        "first": "Bendlin BB",
        "last": "Sager MA",
        "name": "PloS one",
        "pages": "e37720",
        "reference": "22701578",
        "title": "CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "7"
      },
      "evidence": "Elevated P-Tau and P-Tau/Aβ42 levels were associated with lower recognition performance on the Rey auditory verbal learning test",
      "key": "97b8df4d2055cb80db510a1bf9585d8c66e4716aa828a8be4b85641a12a2a97042586e88d3ace680c2854eab7b447392fe66135897fa8a85ab431f31bebc0f2b",
      "line": 244,
      "relation": "negativeCorrelation",
      "source": 22,
      "target": 74
    },
    {
      "citation": {
        "authors": [
          "Alexander AL",
          "Asthana S",
          "Bendlin BB",
          "Birdsill AC",
          "Blennow K",
          "Carlsson CM",
          "Johnson SC",
          "Okonkwo OC",
          "Puglielli L",
          "Ries ML",
          "Rowley HA",
          "Sager MA",
          "Sodhi A",
          "Willette AA",
          "Zetterberg H"
        ],
        "date": "2012-01-01",
        "first": "Bendlin BB",
        "last": "Sager MA",
        "name": "PloS one",
        "pages": "e37720",
        "reference": "22701578",
        "title": "CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "7"
      },
      "evidence": "Elevated P-Tau and P-Tau/Aβ42 levels were associated with lower recognition performance on the Rey auditory verbal learning test",
      "key": "f00edabceac144b111e63a349c71bab10f463a062267af786593a2c89d4a09f25bef967f2fa831004a7e74e92a71eb9e3fc9277efc63fe5feb769c47538d3488",
      "line": 245,
      "relation": "negativeCorrelation",
      "source": 22,
      "target": 21
    },
    {
      "citation": {
        "authors": [
          "Alexander AL",
          "Asthana S",
          "Bendlin BB",
          "Birdsill AC",
          "Blennow K",
          "Carlsson CM",
          "Johnson SC",
          "Okonkwo OC",
          "Puglielli L",
          "Ries ML",
          "Rowley HA",
          "Sager MA",
          "Sodhi A",
          "Willette AA",
          "Zetterberg H"
        ],
        "date": "2012-01-01",
        "first": "Bendlin BB",
        "last": "Sager MA",
        "name": "PloS one",
        "pages": "e37720",
        "reference": "22701578",
        "title": "CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "7"
      },
      "evidence": "Elevated P-Tau and P-Tau/Aβ42 levels were associated with lower recognition performance on the Rey auditory verbal learning test",
      "key": "561b6479ec2032417ea13bc805a3b497f3ad0e553e2c36e27213ea226d5523eabfd337760fb2eba3437eca98a8e4edd191a0b61a9694d9a594a10532e1035e58",
      "line": 245,
      "relation": "negativeCorrelation",
      "source": 21,
      "target": 22
    },
    {
      "annotations": {
        "MeSHDisease": {
          "Lewy Body Disease": true,
          "Parkinson Disease": true
        }
      },
      "citation": {
        "authors": [
          "Becker JA",
          "Gomperts SN",
          "Growdon JH",
          "Hedden T",
          "Johnson KA",
          "Locascio JJ",
          "Marquie M",
          "Rentz DM"
        ],
        "date": "2014-01-01",
        "first": "Marquie M",
        "last": "Gomperts SN",
        "name": "Alzheimer's research &amp; therapy",
        "pages": "52",
        "reference": "25429309",
        "title": "Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.",
        "type": "PubMed",
        "volume": "6"
      },
      "evidence": "DAT concentration in putamen and in caudate were similar in PD and DLB groups and significantly lower than in HCS. Reduced caudate DAT concentration was associated with worse Clinical Dementia Rating Scale-sum of boxes (CDR-SB) scores and visuospatial skills in DLB but not in PD or HCS groups.",
      "key": "2e99c568c75540316843f338f0ee7f5ff48ff783fae5a85e9d2bd1834832c4ae030e3e8172e26276432df158eed5cc91ecb0f6ae5d8c0f71c2888d8255f99d5a",
      "line": 257,
      "relation": "positiveCorrelation",
      "source": 15,
      "target": 4
    },
    {
      "annotations": {
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "c9721984f8f3cb907ff8a11f6ff62187dc227b79842f2e142c93f48860ad698fba9e11f98d804ad378873cd73084a28cc7dd3746c69c46ce6b3dce1e778e5894",
      "line": 273,
      "relation": "negativeCorrelation",
      "source": 63,
      "target": 14
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Published": {
          "CDR story": true
        },
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "d97d71457ac9977aefb997d0a345ba82efe2daa05e9632d7419b3872d6bef69d7311a84c23d2b707093fee0a441575c32931f1ced1f007d0508f329a7586e107",
      "line": 280,
      "relation": "negativeCorrelation",
      "source": 63,
      "target": 71
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Published": {
          "CDR story": true
        },
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "62f4f545d767db4e2f7d78ecc065a7c3aea61a4bd7870c4b5925008efa81715c8a81dea28e04a14de1c783d853739803034b87f58b2deea3fa6b02d79e5b84cb",
      "line": 281,
      "relation": "negativeCorrelation",
      "source": 63,
      "target": 74
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Published": {
          "CDR story": true
        },
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "042add9ab6aae230ff15446c652d59e958d254de219d45289c5c7b9fb08d6e27c0eead271d4c4421a8b2d8b6daa1bf4ab836f632d22fc451c4ddab67ecb1ab72",
      "line": 282,
      "relation": "causesNoChange",
      "source": 63,
      "target": 59
    },
    {
      "annotations": {
        "Subgraph": {
          "DYRK1A subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Aka A",
          "Arbones ML",
          "Blehaut H",
          "Bottlaender M",
          "Corlier F",
          "Corne H",
          "Delabar JM",
          "Dubois B",
          "Hamelin L",
          "Hindié V",
          "Janel N",
          "Lagarde J",
          "Potier MC",
          "Rain JC",
          "Sarazin M",
          "de Souza LC"
        ],
        "date": "2014-08-12",
        "first": "Janel N",
        "last": "Delabar JM",
        "name": "Translational psychiatry",
        "pages": "e425",
        "reference": "25116835",
        "title": "Plasma DYRK1A as a novel risk factor for Alzheimer's disease.",
        "type": "PubMed",
        "volume": "4"
      },
      "evidence": "In a subgroup of patients with early AD (CDR=0.5), lower DYRK1A expression was confirmed. In contrast, no difference was found in levels of DYRK1B, the closest relative of DYRK1A, between AD patients and controls. Further, AD patients exhibited a positive correlation between plasma DYRK1A levels and cerebrospinal fluid tau and phosphorylated-tau proteins, but no correlation with amyloid-β42 levels and Pittsburgh compound B cortical binding.",
      "key": "3763e685691df80eed8194017123d3a778be024ba57ace69aea76f94f331c6416040b086deb3b00cde561991deee35700bad737899db773d5ccd23c7e69cbbea",
      "line": 274,
      "relation": "causesNoChange",
      "source": 64,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Chen Z",
          "Chui D",
          "Fan D",
          "Guo X",
          "Kong F",
          "Tabira T",
          "Tian X",
          "Tong Y",
          "Wang H",
          "Xiao W",
          "Yang H",
          "Yu J",
          "Zhang S",
          "Zhang T",
          "Zhou T"
        ],
        "date": "2014-01-01",
        "first": "Tong Y",
        "last": "Chui D",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "865-78",
        "reference": "24961945",
        "title": "High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.",
        "type": "PubMed",
        "volume": "42"
      },
      "evidence": "In the study, we recruited 40 Chinese elders with different cognitive statuses and investigated concentrations of Mn in whole blood and plasma amyloid-β (Aβ) peptides. Surprisingly, there were significant correlations of Mn with Mini-Mental State Examination score and Clinical Dementia Rating Scale score. In addition, plasma Aβ peptides increased with elevated Mn. ",
      "key": "ff1ad1e7342132ba920bf79025901d975b4daef887851d35747eb4d90b7fdecd2e64d2e579708a49252ca938baabd8caaa4412627b6331f3be466d765250cad4",
      "line": 295,
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        }
      },
      "citation": {
        "authors": [
          "Chen Z",
          "Chui D",
          "Fan D",
          "Guo X",
          "Kong F",
          "Tabira T",
          "Tian X",
          "Tong Y",
          "Wang H",
          "Xiao W",
          "Yang H",
          "Yu J",
          "Zhang S",
          "Zhang T",
          "Zhou T"
        ],
        "date": "2014-01-01",
        "first": "Tong Y",
        "last": "Chui D",
        "name": "Journal of Alzheimer's disease : JAD",
        "pages": "865-78",
        "reference": "24961945",
        "title": "High manganese, a risk for Alzheimer's disease: high manganese induces amyloid-β related cognitive impairment.",
        "type": "PubMed",
        "volume": "42"
      },
      "evidence": "In the study, we recruited 40 Chinese elders with different cognitive statuses and investigated concentrations of Mn in whole blood and plasma amyloid-β (Aβ) peptides. Surprisingly, there were significant correlations of Mn with Mini-Mental State Examination score and Clinical Dementia Rating Scale score. In addition, plasma Aβ peptides increased with elevated Mn. ",
      "key": "079cb9caa73d672dd6ce61fefebfafe0d918fda81a32597b92e7a1b00a770857cdbc5cd409a95ccdf833f28ddde097720a56d985f18e223f83568c68995b6874",
      "line": 296,
      "relation": "positiveCorrelation",
      "source": 1,
      "target": 14
    },
    {
      "key": "318bea75cdddbf75ea5678fdd9f645b25f720436a2ca9c85fd7c291d8c706fb2baf2725961f970e97b2f06bd91842f3cdaf4ccb1a45e57db713c8d0c08a7a90f",
      "relation": "hasVariant",
      "source": 52,
      "target": 38
    },
    {
      "key": "22babfd22e19e8f98fde166e4ec62e6d6767668bf6a96b417eb57e115b45efbee0035ebdcc87ce90cd5ef9e011c7d8a41c9f04425ac593f31ffb42e47e29f682",
      "relation": "hasVariant",
      "source": 52,
      "target": 42
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "dd3db1e4af5caa1b7f0fe11a16db840b271a62b39b949c13c7aaf6080cfdc8e7ea0ab1e087e0682835e118d98c399df9e2a8322bd536bcd3a6d815ecc049776f",
      "line": 313,
      "relation": "association",
      "source": 38,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "507da813d28a43710fa416064a9c8b3e7e45c728c16ac04c89d1cf55371164b432f96f6573866be79c845085c727908d575a871a141fbbef908df722555b6bea",
      "line": 314,
      "relation": "association",
      "source": 42,
      "target": 85
    },
    {
      "key": "f5a3cbe68c9351e62c6116e5e9c3f756ef591403b00b963d004c2d1204fd4620d000e8737bb226c9ab6b83a9ab88f60a2e16112878768edfc0ce21aee4d64b5a",
      "relation": "hasVariant",
      "source": 50,
      "target": 43
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "ec2f2bbcce296747d5ce3b986413e9a6ab856bdf71001aef782af175c57254c82e611f0028c6c3cdcbba09696835f902b8fac43416801fedd7f17f552decf17c",
      "line": 315,
      "relation": "association",
      "source": 43,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "6114b64496aad6799f6b09c93c7982af7c21b4530112c74feaaabff50dca25a02f33ccbbd3d176cb67aff2cf6dedd63ee3388c7b8b26c3ff13e1337e50fba864",
      "line": 313,
      "relation": "association",
      "source": 85,
      "target": 38
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "1c97c57894e5179d7f480549ec1ea7d3146d8f111f4ad41e4c9b1ae3514de5b119953c52ed4f19bcf1cc5fda94d6ab1f87059a14494134cc4c127f3bff1de6e3",
      "line": 314,
      "relation": "association",
      "source": 85,
      "target": 42
    },
    {
      "citation": {
        "authors": [
          "Gharesouran J",
          "Ghojazadeh M",
          "Khorrami A",
          "Rezazadeh M",
          "Talebi M"
        ],
        "date": "2014-12-01",
        "first": "Gharesouran J",
        "last": "Talebi M",
        "name": "Journal of molecular neuroscience : MN",
        "pages": "780-6",
        "reference": "25022885",
        "title": "Genetic evidence for the involvement of variants at APOE, BIN1, CR1, and PICALM loci in risk of late-onset Alzheimer's disease and evaluation for interactions with APOE genotypes.",
        "type": "PubMed",
        "volume": "54"
      },
      "evidence": "Alleles and genotypes of APOE, PICALM rs3851179 and rs541458, and the BIN1 gene rs744373 polymorphism were significantly different between LOAD and control groups.",
      "key": "2b177a8d49a9639950344a986747fbfcf28ad42348be7ae741df1e1fe0522189c6fbf63722f4fa88e1864cd96ebb2d0f5845837b8c5612b1821ccacfe3236b7d",
      "line": 315,
      "relation": "association",
      "source": 85,
      "target": 43
    },
    {
      "citation": {
        "authors": [
          "Bertram L",
          "Blacker D",
          "McQueen MB",
          "Mullin K",
          "Tanzi RE"
        ],
        "date": "2007-01-01",
        "first": "Bertram L",
        "last": "Tanzi RE",
        "name": "Nature genetics",
        "pages": "17-23",
        "reference": "17192785",
        "title": "Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The researchers found that on testing DNA samples from 1,086 well-characterized Alzheimer's disease cases, a single SNP (rs4420638) lying 14 kb distal to the ApoE locus has a powerful association with late-onset AD (corrected p value was 5.3 x 10 e-34).",
      "key": "54876010ccd1daad6ef0d9446071e8f3b12c0b9887b068354a0a51e45279d990298570b70d6dc3ba39cf8aa02bf2098574d680d2714a4968924a81eee1001616",
      "line": 322,
      "relation": "association",
      "source": 85,
      "target": 41
    },
    {
      "citation": {
        "authors": [
          "Bertram L",
          "Blacker D",
          "McQueen MB",
          "Mullin K",
          "Tanzi RE"
        ],
        "date": "2007-01-01",
        "first": "Bertram L",
        "last": "Tanzi RE",
        "name": "Nature genetics",
        "pages": "17-23",
        "reference": "17192785",
        "title": "Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The researchers found that on testing DNA samples from 1,086 well-characterized Alzheimer's disease cases, a single SNP (rs4420638) lying 14 kb distal to the ApoE locus has a powerful association with late-onset AD (corrected p value was 5.3 x 10 e-34).",
      "key": "9231feaa36f1568458fdfd8b6838c94a81ed38f347ac4afbbf57b3be28526fe330e39355d87991f9f6d9da96334303b5174d779dd847cdf37003665a0ff1a465",
      "line": 323,
      "relation": "equivalentTo",
      "source": 85,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Bertram L",
          "Blacker D",
          "McQueen MB",
          "Mullin K",
          "Tanzi RE"
        ],
        "date": "2007-01-01",
        "first": "Bertram L",
        "last": "Tanzi RE",
        "name": "Nature genetics",
        "pages": "17-23",
        "reference": "17192785",
        "title": "Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database.",
        "type": "PubMed",
        "volume": "39"
      },
      "evidence": "The researchers found that on testing DNA samples from 1,086 well-characterized Alzheimer's disease cases, a single SNP (rs4420638) lying 14 kb distal to the ApoE locus has a powerful association with late-onset AD (corrected p value was 5.3 x 10 e-34).",
      "key": "91a1f220d280be761df43e83ce7de282154f9b1ac25f0667e778438acb2cbe235e55269a5e80a238492f5b72a7fd358951477e462db11b877ce9e73899b75939",
      "line": 322,
      "relation": "association",
      "source": 41,
      "target": 85
    },
    {
      "citation": {
        "authors": [
          "Baldaçara L",
          "Borgio JG",
          "Bressan RA",
          "Jackowski AP",
          "Lacerda AL",
          "Montaño MB",
          "Moraes Wdos S",
          "Ramos LR",
          "Tufik S"
        ],
        "date": "2012-11-01",
        "first": "Borgio JG",
        "last": "Bressan RA",
        "name": "Arquivos de neuro-psiquiatria",
        "pages": "839-42",
        "reference": "23175194",
        "title": "Hippocampal volume and CDR-SB can predict conversion to dementia in MCI patients.",
        "type": "PubMed",
        "volume": "70"
      },
      "evidence": "OBJECTIVE: To evaluate the combination of two factors: clinical dementia rating sum of boxes scores (CDR-SB) and hippocampal volume (HV) as predictors of conversion from mild cognitive impairment (MCI) to dementia. METHODS: Twenty-eight individuals (9 normal and 19 with MCI) were classified according to their CDR sum of boxes scores into 3 groups. RESULTS: The hippocampal volume was significantly lower in the high-risk group and in those who developed dementia after two years. The rate of conversion was crescent among the three groups.",
      "key": "a866d6b0540b3d737033ef72ebbacdd059929c3811a1cf41b13de64d136d0d5c4d6d2179a8820afa929c0ca02dfbf3c2d09db46466ac742dadcb4e58d700c57a",
      "line": 331,
      "relation": "negativeCorrelation",
      "source": 18,
      "target": 4
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "84d48b885993cbfd26493e3715feffa93a3f54d12667deac6bac1be470507fb651d0f4a43a9870f21f38426d00f9464e47201bfc3d23054ddf8c79d8b2d31d86",
      "line": 500,
      "relation": "association",
      "source": 18,
      "target": 35
    },
    {
      "annotations": {
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Bishnoi RJ",
          "Palmer RF",
          "Royall DR"
        ],
        "date": "2015-07-01",
        "first": "Royall DR",
        "last": "Palmer RF",
        "name": "Neurobiology of aging",
        "pages": "2232-2240",
        "reference": "26043140",
        "title": "Serum IGF-BP2 strongly moderates age's effect on cognition: a MIMIC analysis.",
        "type": "PubMed",
        "volume": "36"
      },
      "evidence": "In this analysis, we construct a δ ortholog representing the 'cognitive correlates of age' (cAGE). cAGE largely mediates age's effects on dementia severity, as rated by the Clinical Dementia Rating Scale Sum of boxes and has an area under the receiver operating curve = 0.96 for the diagnosis of Alzheimer's Disease versus controls.",
      "key": "019b44aab6a32f64299fcd4711c6e8a6e01ff6202aabfbb4964bf9ec45cc5860f75299c27342c221a9209c7fc7ce500ab9ef21c839fe0f6a47931a4b134a1939",
      "line": 338,
      "relation": "association",
      "source": 5,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "urine": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Among these three markers, the lower 3-HPMA/Cre ratio was most strongly correlated with the decline of MMSE (Mini-Mental State Examination) and the increase in CDRsob (Clinical Dementia Rating Scale Sum of Boxes Scores).",
      "key": "5e07c43ade4b36927795978d7b095ebb8310c1625fdce0cf392dfdcb1b55ec1a29a604f4f3b0d959c29b73cbfd5ff5b4e60f4c218c1faed94470221ed61c6f70",
      "line": 347,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "urine": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Among these three markers, the lower 3-HPMA/Cre ratio was most strongly correlated with the decline of MMSE (Mini-Mental State Examination) and the increase in CDRsob (Clinical Dementia Rating Scale Sum of Boxes Scores).",
      "key": "3aee627d88135e35a65ce1b3557794b9287fb034bfb2aa63484c9f00374e3b9c19bf039cae6aa7ddd3f5712b240d477f9086424860162e2f447fedd193ab3781",
      "line": 348,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 20
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "1f10e424660d559d9f1d90fa10fe08ce111e269212b7bdad6c3842b7e3eca35517824147d013f5ea25074b885dacedeca63a2bb923114872a423d10372848c15",
      "line": 355,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 10
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "778658654e3e12dd4dcdbc28683bab25a4c48cb03de033b38bf4c84f8aa45a3da138f677a09c1782a9b1ad61fdd203d889ada4b96f1f4cbc4a8c6f7559ce4072",
      "line": 358,
      "relation": "positiveCorrelation",
      "source": 9,
      "target": 7
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "b4d0291dc5e94133b3b2a02e5055ec4e35241b4828e2a2f5f87a4a96994e52d554049190f76efb7637e90c81642711ead5eb44a88b9d4c2f6d9d29a2d9b1b975",
      "line": 359,
      "relation": "negativeCorrelation",
      "source": 9,
      "target": 3
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "efed56a2bf50b48f8c1073f68a62e97aa41a47d3e02f3fb39d2eedf737235c5b336f3db7104e17857e794596189663845e9818791ef38e46d8b686356c04fd6c",
      "line": 355,
      "relation": "negativeCorrelation",
      "source": 10,
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "719e22be1c040566ebe6602e1ab4927be2fcb40570fa247b3e7665d514acdd4ccf27f6f264486e60c98fbc441738be762a3981f2ba5f61a67145b11f8a4ec152",
      "line": 358,
      "relation": "positiveCorrelation",
      "source": 7,
      "target": 9
    },
    {
      "citation": {
        "authors": [
          "Higashi K",
          "Igarashi K",
          "Kashiwagi K",
          "Kuni K",
          "Mizoi M",
          "Nakamura M",
          "Saiki R",
          "Toida T",
          "Uemura K",
          "Waragai M",
          "Yoshida M"
        ],
        "date": "2015-02-20",
        "first": "Yoshida M",
        "last": "Igarashi K",
        "name": "Clinica chimica acta; international journal of clinical chemistry",
        "pages": "115-21",
        "reference": "25542982",
        "title": "Distinguishing mild cognitive impairment from Alzheimer's disease with acrolein metabolites and creatinine in urine.",
        "type": "PubMed",
        "volume": "441"
      },
      "evidence": "Furthermore, reduction in 3-HPMA/Cre in urine was well correlated with increase in Aβ40/42 in plasma in demented subjects.",
      "key": "837c7a0d022fb99c8cdf71eeff7379967bc888822fdb3afac291c44df121956b4b0f729b556eb5be8ce50c121ba962f6702330838b5ec392dfdffdb5e823cb69",
      "line": 359,
      "relation": "negativeCorrelation",
      "source": 3,
      "target": 9
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "MeSHDisease": {
          "Frontotemporal Dementia": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Ahlijanian M",
          "Berisha F",
          "Boxer AL",
          "Coppola G",
          "Grinberg LT",
          "Hall T",
          "Karydas A",
          "Klepac K",
          "Kramer JH",
          "Meredith J Jr",
          "Miller BL",
          "Rabinovici G",
          "Rosen H",
          "Scherling CS",
          "Seeley W"
        ],
        "date": "2014-01-01",
        "first": "Scherling CS",
        "last": "Boxer AL",
        "name": "Annals of neurology",
        "pages": "116-26",
        "reference": "24242746",
        "title": "Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration.",
        "type": "PubMed",
        "volume": "75"
      },
      "evidence": "CSF NfL, but not other CSF measures, correlated with CDRsb and neuropsychological measures in FTD, but not in other diagnostic groups.",
      "key": "8396e9ce1095ba203d7cb259daabed24c5b7f29671cbc344940156596be5f7f66170c2e0898fec16967d4447176e118d57907f82018c7333fe8e1fe39ed0009d",
      "line": 371,
      "relation": "positiveCorrelation",
      "source": 76,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "caudate nucleus": true
        },
        "MeSHDisease": {
          "Lewy Body Disease": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Becker JA",
          "Gomperts SN",
          "Growdon JH",
          "Hedden T",
          "Johnson KA",
          "Locascio JJ",
          "Marquie M",
          "Rentz DM"
        ],
        "date": "2014-01-01",
        "first": "Marquie M",
        "last": "Gomperts SN",
        "name": "Alzheimer's research &amp; therapy",
        "pages": "52",
        "reference": "25429309",
        "title": "Striatal and extrastriatal dopamine transporter levels relate to cognition in Lewy body diseases: an (11)C altropane positron emission tomography study.",
        "type": "PubMed",
        "volume": "6"
      },
      "evidence": "Reduced caudate DAT concentration was associated with worse Clinical Dementia Rating Scale-sum of boxes (CDR-SB) scores and visuospatial skills in DLB but not in PD or HCS groups.",
      "key": "81034b4d0aa79e999e378128a14973e2d4cba6612a44b604e8e41e470a105889703edc66790b78c1166341c6d6eb208d19ca3da2f8f3ee6fcdf364172b4defcf",
      "line": 382,
      "relation": "negativeCorrelation",
      "source": 80,
      "target": 4
    },
    {
      "key": "440256aa4c457d448fe9ceafdff41aecbd12597ebcc666097fd6201cad0768ceb19beaae8d05ffd30e544dac2543d260d4db746046010d3a50bae44f43aca87d",
      "relation": "hasComponent",
      "source": 27,
      "target": 6
    },
    {
      "key": "7ce9cc2e931fa2c4750e45d13345de07e7be1c5b5ca29c04b8ce369d5dce85e0f1b844807d46dcdebda64ed0315ab218eb5a5fbd4d95bc6b58f95579bcbff0f3",
      "relation": "hasComponent",
      "source": 27,
      "target": 84
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "3b02a5b3a35b0a3a8c6cef0e9a3b16d34cecebf9faacba3556b3b768ed317e1d2f59ddb709982c70b069c7ce4a8179cb38ce5eae86dda05993f0173b3212b4a3",
      "line": 396,
      "relation": "negativeCorrelation",
      "source": 27,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "091f8730eccfe59b38ba9ccda4bbd5c6c00fd915c2864ddce1ee14f5ac5ad0b7ba5474f5f045c2e5c625c2d8501c80fd87f347501481d25fdef41ad66082716a",
      "line": 397,
      "relation": "negativeCorrelation",
      "source": 27,
      "target": 20
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "e9979722ff69b648ee8f06173b3381db51ca60a3283109b344419ba42020fbc504fed8d168eca2fde5bb56c1fa670dd666192076f179e49ceaed3d560276cc28",
      "line": 398,
      "relation": "negativeCorrelation",
      "source": 27,
      "target": 19
    },
    {
      "annotations": {
        "Anatomy": {
          "inferior parietal cortex": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Biomarkers Consortium PET Radioligand Project Team.",
          "Corona W",
          "Innis RB",
          "Jenko KJ",
          "Kimura N",
          "Kreisl WC",
          "Lyoo CH",
          "McGwier M",
          "McMahon FJ",
          "Morse CL",
          "Pike VW",
          "Snow J",
          "Turner RS",
          "Zoghbi SS"
        ],
        "date": "2013-07-01",
        "first": "Kreisl WC",
        "last": "Innis RB",
        "name": "Brain : a journal of neurology",
        "pages": "2228-38",
        "reference": "23775979",
        "title": "In vivo radioligand binding to translocator protein correlates with severity of Alzheimer's disease.",
        "type": "PubMed",
        "volume": "136"
      },
      "evidence": "(11)C-PBR28 binding inversely correlated with performance on Folstein Mini-Mental State Examination, Clinical Dementia Rating Scale Sum of Boxes, Logical Memory Immediate (Wechsler Memory Scale Third Edition), Trail Making part B and Block Design (Wechsler Adult Intelligence Scale Third Edition) tasks, with the largest correlations observed in the inferior parietal lobule.",
      "key": "6b2d73f7e1c25982770d5e4e55d96a30bc2596867026c8fcb9eb29c7e025294694dfde773bfc082d9a786c84c9ef4f31380bdf2b84554077f5cd376ae2c7d2b0",
      "line": 398,
      "relation": "negativeCorrelation",
      "source": 19,
      "target": 27
    },
    {
      "annotations": {
        "Condition": {
          "increasing severity": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "AIBL Research Group.",
          "Ames D",
          "Bush AI",
          "Darby D",
          "Ellis KA",
          "Lim YY",
          "Maruff P",
          "Masters CL",
          "Pietrzak RH",
          "Schembri A",
          "Snyder PJ",
          "Szoeke C"
        ],
        "date": "2013-01-01",
        "first": "Maruff P",
        "last": "Masters CL",
        "name": "BMC psychology",
        "pages": "30",
        "reference": "25566378",
        "title": "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.",
        "type": "PubMed",
        "volume": "1"
      },
      "evidence": "Poorer performance on the memory composite was also associated with worse performance on the Mini Mental State Exam and increasing severity on the Clinical Dementia Rating Scale sum of boxes score.",
      "key": "e3db59c1c3e0f7342b93097b49a77fcdf286a9d0dfcb8cb6e81c38d7a1da0193774879531abe4b94df808844b520f1c33b9ed69c7a5075e107f36ab292d35dc0",
      "line": 409,
      "relation": "positiveCorrelation",
      "source": 86,
      "target": 20
    },
    {
      "annotations": {
        "Condition": {
          "increasing severity": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "AIBL Research Group.",
          "Ames D",
          "Bush AI",
          "Darby D",
          "Ellis KA",
          "Lim YY",
          "Maruff P",
          "Masters CL",
          "Pietrzak RH",
          "Schembri A",
          "Snyder PJ",
          "Szoeke C"
        ],
        "date": "2013-01-01",
        "first": "Maruff P",
        "last": "Masters CL",
        "name": "BMC psychology",
        "pages": "30",
        "reference": "25566378",
        "title": "Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's disease.",
        "type": "PubMed",
        "volume": "1"
      },
      "evidence": "Poorer performance on the memory composite was also associated with worse performance on the Mini Mental State Exam and increasing severity on the Clinical Dementia Rating Scale sum of boxes score.",
      "key": "b050482e5d6acb1ef2d3fd37070850c975bbaad85b71521cc3f3b4b958a8070aa0bcd27a1c8e72e4b5db399efccad23b06adf94c6b3a4fb36cd3050a803ad758",
      "line": 410,
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 4
    },
    {
      "annotations": {
        "Anatomy": {
          "anterior cingulate cortex": true,
          "cingulate cortex": true,
          "putamen": true
        },
        "MeSHDisease": {
          "Alzheimer Disease": true
        },
        "Species": {
          "9606": true
        }
      },
      "citation": {
        "authors": [
          "Drzezga A",
          "Förstl H",
          "Grimmer T",
          "Henriksen G",
          "Klunk WE",
          "Kurz A",
          "Mathis CA",
          "Wester HJ"
        ],
        "date": "2009-12-01",
        "first": "Grimmer T",
        "last": "Drzezga A",
        "name": "Neurobiology of aging",
        "pages": "1902-9",
        "reference": "18346821",
        "title": "Clinical severity of Alzheimer's disease is associated with PIB uptake in PET.",
        "type": "PubMed",
        "volume": "30"
      },
      "evidence": "The linear regression analyses showed that the CDR-SOB explained approximately 11-22% of the variance of [11C]PIB uptake. The association attained statistical significance in both frontal, in both anterior cingulate cortices, and in both putamina.",
      "key": "51b4f4392dce7b3967f8a6270f6f90aa94651b510fd3dca8dee96eda2f415979abfaa8f98f2d39e391ee508d3173973348a0e9a03d9138e8527b390de30d1ba9",
      "line": 422,
      "relation": "positiveCorrelation",
      "source": 8,
      "target": 4
    },
    {
      "annotations": {
        "CellStructure": {
          "Cell Nucleus": true,
          "Mitochondria": true
        },
        "Published": {
          "CDR story": true
        }
      },
      "citation": {
        "authors": [
          "Akhtar A",
          "Avilov S",
          "Becker T",
          "Böttinger L",
          "Chatterjee A",
          "Eimer S",
          "Gilsbach R",
          "Hein L",
          "Kretz O",
          "Lucci J",
          "Mårtensson CU",
          "Panhale A",
          "Pfanner N",
          "Preissl S",
          "Sahyoun AH",
          "Seyfferth J",
          "Stehle T"
        ],
        "date": "2016-10-20",
        "first": "Chatterjee A",
        "last": "Akhtar A",
        "name": "Cell",
        "pages": "722-738.e23",
        "reference": "27768893",
        "title": "MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria.",
        "type": "PubMed",
        "volume": "167"
      },
      "evidence": " We report that the well-known nuclear MYST family acetyl transferase MOF and a subset of its non-specific lethal complex partners reside in mitochondria. MOF regulates oxidative phosphorylation by controlling expression of respiratory genes from both nuclear and mtDNA in aerobically respiring cells",
      "key": "95dbd5f98e941970e0873d712f30f012d0088e084f38db64e3d925e7bfdb44b3eb95eda363be3dda949b6ce9dfaebdab33a8944265bf6fa9798d085b87c10fc7",
      "line": 444,
      "relation": "association",
      "source": 69,
      "target": 25
    },
    {
      "annotations": {
        "CellStructure": {
          "Cell Nucleus": true,
          "Mitochondria": true
        },
        "Published": {
          "CDR story": true
        }
      },
      "citation": {
        "authors": [
          "Akhtar A",
          "Avilov S",
          "Becker T",
          "Böttinger L",
          "Chatterjee A",
          "Eimer S",
          "Gilsbach R",
          "Hein L",
          "Kretz O",
          "Lucci J",
          "Mårtensson CU",
          "Panhale A",
          "Pfanner N",
          "Preissl S",
          "Sahyoun AH",
          "Seyfferth J",
          "Stehle T"
        ],
        "date": "2016-10-20",
        "first": "Chatterjee A",
        "last": "Akhtar A",
        "name": "Cell",
        "pages": "722-738.e23",
        "reference": "27768893",
        "title": "MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria.",
        "type": "PubMed",
        "volume": "167"
      },
      "evidence": "MOF (KAT8) regulates oxidative phosphorylation by controlling expression of respiratory genes from both nuclear and mtDNA in aerobically respiring cells.",
      "key": "0ff8fce5ebbddeb013a4eb1a5ff7597b8cda58bd5a23953606148d9015c5f7e19f2c71daa37a209995bef879a0acba4449fd82bc8b3859414b29f08f76412419",
      "line": 449,
      "relation": "regulates",
      "source": 69,
      "target": 26
    },
    {
      "annotations": {
        "CellStructure": {
          "Cell Nucleus": true,
          "Mitochondria": true
        },
        "Published": {
          "CDR story": true
        }
      },
      "citation": {
        "authors": [
          "Akhtar A",
          "Avilov S",
          "Becker T",
          "Böttinger L",
          "Chatterjee A",
          "Eimer S",
          "Gilsbach R",
          "Hein L",
          "Kretz O",
          "Lucci J",
          "Mårtensson CU",
          "Panhale A",
          "Pfanner N",
          "Preissl S",
          "Sahyoun AH",
          "Seyfferth J",
          "Stehle T"
        ],
        "date": "2016-10-20",
        "first": "Chatterjee A",
        "last": "Akhtar A",
        "name": "Cell",
        "pages": "722-738.e23",
        "reference": "27768893",
        "title": "MOF Acetyl Transferase Regulates Transcription and Respiration in Mitochondria.",
        "type": "PubMed",
        "volume": "167"
      },
      "evidence": " We report that the well-known nuclear MYST family acetyl transferase MOF and a subset of its non-specific lethal complex partners reside in mitochondria. MOF regulates oxidative phosphorylation by controlling expression of respiratory genes from both nuclear and mtDNA in aerobically respiring cells",
      "key": "9dc02b132572472e5f4683103be06300745a8572d9bdfdab7a3b0f3817e71227d950df64a849a79e5a090813efd29156a8dd3fdb083e8e67aa627c0ca8f093e4",
      "line": 444,
      "relation": "association",
      "source": 25,
      "target": 69
    },
    {
      "annotations": {
        "CellStructure": {
          "Mitochondria": true
        },
        "Subgraph": {
          "Reactive oxygen species subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Khan SM",
          "Onyango IG"
        ],
        "date": "2006-09-01",
        "first": "Onyango IG",
        "last": "Khan SM",
        "name": "Current Alzheimer research",
        "pages": "339-49",
        "reference": "17017864",
        "title": "Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "3"
      },
      "evidence": "Mitochondria are pivotal in controlling cell life and death not only by producing ATP, and sequestering calcium, but by also generating free radicals and serving as repositories for proteins which regulate the intrinsic apoptotic pathway. Perturbations in the physiological function of mitochondria inevitably disturb cell function, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of a number of neurodegenerative disorders including AD.",
      "key": "bfd476a6449f8cfc7a7560c559a7fcec620d1d216cee9dbf7f0d7aac8ec26a41dc8be301553560655d9f0c3fbc9c90414de3be99f3fd06a75210b52a862b12ea",
      "line": 461,
      "relation": "increases",
      "source": 88,
      "target": 2
    },
    {
      "annotations": {
        "CellStructure": {
          "Mitochondria": true
        },
        "Subgraph": {
          "Reactive oxygen species subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Khan SM",
          "Onyango IG"
        ],
        "date": "2006-09-01",
        "first": "Onyango IG",
        "last": "Khan SM",
        "name": "Current Alzheimer research",
        "pages": "339-49",
        "reference": "17017864",
        "title": "Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "3"
      },
      "evidence": "Mitochondria are pivotal in controlling cell life and death not only by producing ATP, and sequestering calcium, but by also generating free radicals and serving as repositories for proteins which regulate the intrinsic apoptotic pathway. Perturbations in the physiological function of mitochondria inevitably disturb cell function, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of a number of neurodegenerative disorders including AD.",
      "key": "5ff10260f1853add0b96ec04008ba18bac2eee6253caf5fe4c03cbf1bd691527fd754490fe7af601adaa1b056386d08bf9a549eaef61c815bd4172994d321f42",
      "line": 462,
      "relation": "increases",
      "source": 88,
      "target": 24
    },
    {
      "annotations": {
        "CellStructure": {
          "Mitochondria": true
        },
        "Subgraph": {
          "Reactive oxygen species subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Khan SM",
          "Onyango IG"
        ],
        "date": "2006-09-01",
        "first": "Onyango IG",
        "last": "Khan SM",
        "name": "Current Alzheimer research",
        "pages": "339-49",
        "reference": "17017864",
        "title": "Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "3"
      },
      "evidence": "Mitochondria are pivotal in controlling cell life and death not only by producing ATP, and sequestering calcium, but by also generating free radicals and serving as repositories for proteins which regulate the intrinsic apoptotic pathway. Perturbations in the physiological function of mitochondria inevitably disturb cell function, sensitize cells to neurotoxic insults and may initiate cell death, all significant phenomena in the pathogenesis of a number of neurodegenerative disorders including AD.",
      "key": "a43e85a5f6913bfeafc6a17084bb138cc5445132da311a9f115a983c45c820cb03ffd4015e941e5b3e281a5f0e94750631e0aaeed0c3c8e3dcbb694a5a6007ed",
      "line": 463,
      "relation": "increases",
      "source": 88,
      "target": 23
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "f183b46870ab748cca1fa8e61ecce8e3700a2196794e82f78a1cd0998d97ca806ba5d25f816170630f81ba7179626657de7f7f41e22579c47ee203f69567f8ed",
      "line": 496,
      "relation": "association",
      "source": 67,
      "target": 30
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "df239eee732101ad6e601de59acc4bdc6240e7f26e0ffcb058392c49f5e1ce35a487ed19ee49ba569076ae50cad4bf5e83c70b70a6f181a5c8677832e8c515c4",
      "line": 496,
      "relation": "association",
      "source": 30,
      "target": 67
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "3a1b75af3c26dbbf727335ad035109cdc65b474158fa8678a5bcbd6c59ec048cf11888c24982a5fa37b2ef77fe78d1610139c13d3cc5283bfcf2f025517af71b",
      "line": 497,
      "relation": "association",
      "source": 30,
      "target": 35
    },
    {
      "annotations": {
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "f69655fe28eaa1c8cef5d4f8cf07a40f55f87d1bfa9601316d574740bafc9babf79d1831c09d130b7d2ac4cac03f695aad399f6220f6294a9901c0283b1480e1",
      "line": 497,
      "relation": "association",
      "source": 35,
      "target": 30
    },
    {
      "annotations": {
        "Confidence": {
          "Low": true
        },
        "MeSHAnatomy": {
          "Hippocampus": true
        }
      },
      "citation": {
        "authors": [
          "Amin N",
          "Amouyel P",
          "Barber R",
          "Becker T",
          "Beecham GW",
          "Beekly D",
          "Bellenguez C",
          "Bennett DA",
          "Berr C",
          "Bis JC",
          "Boada M",
          "Boland A",
          "Brayne C",
          "Buxbaum JD",
          "Campion D",
          "Cantwell LB",
          "Carasquillo M",
          "Choi SH",
          "Chouraki V",
          "Chung J",
          "Clarke R",
          "Crane PK",
          "Cruchaga C",
          "Dartigues JF",
          "De Jager P",
          "Denning N",
          "Deramecourt V",
          "Destefano AL",
          "Dufouil C",
          "Dunstan ML",
          "Eiriksdottir G",
          "Emilsson V",
          "Escott-Price V",
          "Evans D",
          "Farrer LA",
          "Fievet N",
          "Fitzpatrick AL",
          "Foroud TM",
          "Fox NC",
          "Gill M",
          "Goate AM",
          "Grenier-Boley B",
          "Gudnason V",
          "Haines JL",
          "Hamilton-Nelson KL",
          "Hampel H",
          "Hannequin D",
          "Hanon O",
          "Hardy J",
          "Harold D",
          "Hofman A",
          "Holmans P",
          "Holmes C",
          "IGAP Consortium.",
          "Ibrahim-Verbaas CA",
          "Ikram MA",
          "Jakobsdóttir J",
          "Jones L",
          "Jonsson PV",
          "Jun G",
          "Kamatani Y",
          "Kamboh MI",
          "Kauwe JS",
          "Kukull WA",
          "Kunkle BW",
          "Lambert JC",
          "Larson EB",
          "Lathrop M",
          "Launer LJ",
          "Laza AR",
          "Letenneur L",
          "Lopez OL",
          "Love S",
          "Lunetta KL",
          "Maier W",
          "Martin ER",
          "Mayeux R",
          "Mead S",
          "Montine TJ",
          "Morgan K",
          "Mosley TH Jr",
          "Naj AC",
          "Nalls MA",
          "Nöthen MM",
          "O'Donovan MC",
          "Pasquier F",
          "Passmore P",
          "Pastor P",
          "Pericak-Vance MA",
          "Powell JF",
          "Psaty BM",
          "Ramirez A",
          "Reiman EM",
          "Rotter JI",
          "Rujescu D",
          "Schellenberg GD",
          "Schmidt H",
          "Schmidt R",
          "Seshadri S",
          "Sims R",
          "Smith AV",
          "St George-Hyslop PH",
          "Tsolaki M",
          "Tzourio C",
          "Tárraga L",
          "Valladares O",
          "Van Broeckhoven C",
          "Vronskaya M",
          "Wang LS",
          "Wendland JR",
          "Wilhelmsen KC",
          "Williams J",
          "Winslow AR",
          "Younkin SG",
          "Zelenika D",
          "de Bruijn RF",
          "van Duijn CM",
          "van der Lee SJ"
        ],
        "date": "2016-01-01",
        "first": "Jun G",
        "last": "Farrer LA",
        "name": "Molecular psychiatry",
        "pages": "108-17",
        "reference": "25778476",
        "title": "A novel Alzheimer disease locus located near the gene encoding tau protein.",
        "type": "PubMed",
        "volume": "21"
      },
      "evidence": "Expression quantitative trait locus analysis revealed that rs113986870, one of the GWS SNPs near rs2732703, is significantly associated with four KANSL1 probes that target transcription of the first translated exon and an untranslated exon in hippocampus (P≤1.3x10−8), frontal cortex (P≤1.3x10−9), and temporal cortex (P≤1.2x10−11)",
      "key": "d086de2b9a98c6181ebf93582665a393772732dd67c2b27ceb6d2c6113a726f39729ac3187cc9036058b3eb03c66f44e0e5d7b8eee8772e1cacaa876bace7827",
      "line": 500,
      "relation": "association",
      "source": 35,
      "target": 18
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"manganese(2+)\")",
      "function": "Abundance",
      "id": "0fd5d87a0d5d1001d9487c0f01e4667ed329eed63cb4524071242abd4be8de5edd1da684a1bb1aef97ca83a35dd3a5123efce34845214f757d5793b25923c3f0",
      "name": "manganese(2+)",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"reactive oxygen species\")",
      "function": "Abundance",
      "id": "5da7879846ec42231f9176e97a7f14c4b573807576fa75be6e3acb71f391f25971e33d2f7fb886003ebd8020ab592e1424e2fc106f91213d546078dd09fabb65",
      "name": "reactive oxygen species",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:creatinine)",
      "function": "Abundance",
      "id": "6bfe638f0421f1dd8f6a66d590d8e026ab026b1662585fd58bf5c214656bdcc7fdca342d789f24812f3bd73d82d750197e3c9fd30b30833d62c8a417c0b243e2",
      "name": "creatinine",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:\"CDR - Sum of Boxes\")",
      "function": "Abundance",
      "id": "58c801b0070714798e9400e81507795a9e6799c12ce45e86a27e2db4cae33ddedd3bc7d9f0ab9f305d78ba8f6ef01d1d33baf456c753189cbff606e02c99e59d",
      "name": "CDR - Sum of Boxes",
      "namespace": "CONSO"
    },
    {
      "bel": "a(EFO:\"cognitive decline measurement\")",
      "function": "Abundance",
      "id": "8b5cd2e21f8bcd096049b11c6c9d2799c7c5155092e52ffcc230814b28985e0a1cc0d7104c8b34229ebb321c1376a6b6ccc2683ce3f81ca3d17b5743bdc1ce34",
      "name": "cognitive decline measurement",
      "namespace": "EFO"
    },
    {
      "bel": "a(InChI:\"InChI=1S/C22H21NO3/c1-17(24)23(16-18-10-6-8-14-21(18)25-2)20-13-7-9-15-22(20)26-19-11-4-3-5-12-19/h3-15H,16H2,1-2H3/i2-1\")",
      "function": "Abundance",
      "id": "8fdafa466859a5b61aeb791c8e5b4e79d6db9cb307b1164f9a93f9d44410b5543206ca688e297fa69db0d7d2adaa0dd490e44c091e6f9797b3ff5358d82abb42",
      "name": "InChI=1S/C22H21NO3/c1-17(24)23(16-18-10-6-8-14-21(18)25-2)20-13-7-9-15-22(20)26-19-11-4-3-5-12-19/h3-15H,16H2,1-2H3/i2-1",
      "namespace": "InChI"
    },
    {
      "bel": "a(InChI:\"InChI=1S/C8H15NO4S/c1-6(11)9-7(8(12)13)5-14-4-2-3-10/h7,10H,2-5H2,1H3,(H,9,11)(H,12,13)/t7-/m0/s1\")",
      "function": "Abundance",
      "id": "66099dabf7e31b156d12a24fa83523f3c8dbaf8de2ed21b41073d941874d579175e4dce816511e77356172f7e5933b0ef4ef8546e010cf3dba040e64fb68619d",
      "name": "InChI=1S/C8H15NO4S/c1-6(11)9-7(8(12)13)5-14-4-2-3-10/h7,10H,2-5H2,1H3,(H,9,11)(H,12,13)/t7-/m0/s1",
      "namespace": "InChI"
    },
    {
      "bel": "a(MESHC:\"2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole\")",
      "function": "Abundance",
      "id": "ced0c170494a73bd2f137c1d1801891178df896e29ba36e1218893a7ecdf288124eb0eaf944d452a86e68cd1e4272a06e247f5962937e774471aa02868191448",
      "name": "2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole",
      "namespace": "MESHC"
    },
    {
      "bel": "a(NIFT:\"3-HPMA/Cre ratio\")",
      "function": "Abundance",
      "id": "8b61e24d122455620813837d13a97328df6fe0622a163cb48556645c6d96d5b679940ca7c5a3b33b9e6c4b7b664bfbfae3ae252abd06573d0c50ce45b3f44815",
      "name": "3-HPMA/Cre ratio",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Abeta_40_42_ratio\")",
      "function": "Abundance",
      "id": "d5c6b5a3c64a52c5d8f8e8e1e8aa0aeaff3c52efc68249ecca3edc8587d5d360c5c0d08dd359aaa79a4fe2bd6371b12b4a157866948236caa81c6f421c6205f8",
      "name": "Abeta_40_42_ratio",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Alzheimer questionnaire\")",
      "function": "Abundance",
      "id": "2a4cd90645ebcd419ba878179efa6a6aeb50b5f38eaf4937d3c5931ff4f92ffb673b094578cb1405402c38ad285920b1d89abb9680230bd12a5033cf10591a00",
      "name": "Alzheimer questionnaire",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Alzheimers disease assessment scale\")",
      "function": "Abundance",
      "id": "7d92b58b4e2744c0a71b71f7816858940eaa93ea3888a82fda10e09ca3b5c113768b855c04248cb594aad2028a472a601e2a563900b06c50d99f66937b24b485",
      "name": "Alzheimers disease assessment scale",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Brain atrophy\")",
      "function": "Abundance",
      "id": "5ed61ecc5dc4b8e65969096aa5d9ff3e40c48988601a46015f3fccc9aac52c6d11c2f245a99a0863f6f5036b08a020172cf3161e94424056e11648f224b695c1",
      "name": "Brain atrophy",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Clinical dementia rating\")",
      "function": "Abundance",
      "id": "bcbc37f3c8a561e80807e34eefd53c148248e37a95505c47b59d54fba1bf31b07a0a7b38ab8116a6942553a7d4bbcf1e76231f5b22f5ee6874b3cb9d9b2d0aa4",
      "name": "Clinical dementia rating",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Dopamine transporter scan\")",
      "function": "Abundance",
      "id": "22ccb10de2d25bc194148b74c702d8d3ad4284057b3a9ae9194686be89eb0b1056351af7da8fff61506b6d8de88edec4a05a58ea558dce0d09a422103c3bf5c4",
      "name": "Dopamine transporter scan",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Fractional anisotropy\")",
      "function": "Abundance",
      "id": "8faf48dcb68f3b4049347066a6a21b32efca0749d79e934c0c4101ecc11a822dc485cb76757770bc2ed72b26c22399f9f258426504be084582ffb5a427df22da",
      "name": "Fractional anisotropy",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Heidelberg edge perimetry\")",
      "function": "Abundance",
      "id": "2d26145b3b0813890b9bb3ac2beebae200eb175e4b2a2808936455470d01d225e7b5f06843db807b2116d4b231b8f7426a0ef57abde4c4e8c2fb6da9a59e9572",
      "name": "Heidelberg edge perimetry",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Hippocampus volume\")",
      "function": "Abundance",
      "id": "21d0c9b5ea612ad45750d49bf882eb9d2ee3294cab794c03047ec016bef35f23a906eb2c451e1e3a40152329a75bf296b96c29a8abb6d575ab0fcb029b2ab8e9",
      "name": "Hippocampus volume",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Logical Memory Immediate\")",
      "function": "Abundance",
      "id": "cff8ecc02ade6bbbe0731685c4ec1508e91361e130a4a827fe568c96635ad801dd8357fbd31dc5092511b6f38855710f4130a603a2836707596b1cf363407421",
      "name": "Logical Memory Immediate",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Mini mental state exam\")",
      "function": "Abundance",
      "id": "04460604b805c2faa2d22e9c96efc786555b2f90dff735301dbcf7b961077179c2cb134ad19ba5b32f22d13804a4f41c1de8e23b913b8b0b63251c0fe24cfb00",
      "name": "Mini mental state exam",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Ratio phospho tau to abeta 42 test\")",
      "function": "Abundance",
      "id": "be24025e4280e896ad761658a340ae468bbabf56ead0c3cfe480a2a7692ab2661d929a94611761ee4390e30b1fb02886efbd646ad55213877c784f452c4e2ec6",
      "name": "Ratio phospho tau to abeta 42 test",
      "namespace": "NIFT"
    },
    {
      "bel": "a(NIFT:\"Rey auditory verbal learning test\")",
      "function": "Abundance",
      "id": "70e428941fa20efe0433f16855452be31235a6c57e1aeea38b39ac43904ac5873491e7a0116881af66cc0fbd724239ebea76eebefaf50820b1eedf4d7421e4d6",
      "name": "Rey auditory verbal learning test",
      "namespace": "NIFT"
    },
    {
      "bel": "bp(GO:\"apoptotic process\")",
      "function": "BiologicalProcess",
      "id": "1c5172472cbecf29eeb8e86a4cac2d13123fe572356f00e2f98302422560bbda2854e3b1f8fdf85396655393cf5ddb42e0db210c3d3fc146fa358cc8d0ed0254",
      "name": "apoptotic process",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"cell death\")",
      "function": "BiologicalProcess",
      "id": "b2ecb9d87645a0a7d5efbe2c9eeeaa14a705a36b6cdf787e071ba334fdd12b4caaf12b88508b99a8974005549b3c8123c9481c5d969630df072082b07e4dc586",
      "name": "cell death",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:\"regulation of oxidative phosphorylation\")",
      "function": "BiologicalProcess",
      "id": "261c2a51635a02a8246e5acf36ce380fbbea7015cb566a414c7c937e9a5f7650baf111f03d6d59c3f17c897cf4277855d87f36ecbf2df70a5e363a1e3733d4a4",
      "name": "regulation of oxidative phosphorylation",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"respiratory chain complex\")",
      "function": "Complex",
      "id": "df85345295246cd4c7c594148e3e35a9f3184a03509ea74ec800215e7448169c4550374ed5e99b5b2bd7b77c5a698fc15c648b73065df4011d37e67cc48fff15",
      "name": "respiratory chain complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(a(InChI:\"InChI=1S/C22H21NO3/c1-17(24)23(16-18-10-6-8-14-21(18)25-2)20-13-7-9-15-22(20)26-19-11-4-3-5-12-19/h3-15H,16H2,1-2H3/i2-1\"), p(HGNC:TSPO))",
      "function": "Complex",
      "id": "ee40da5db8c78d6db9f434c695feb8318de53b2006efda6cf4442ad231d4e0922b6413c83874de82e33b8ad25450abcf273e5a1770bd61320129d701dd59ecb1",
      "members": [
        {
          "bel": "a(InChI:\"InChI=1S/C22H21NO3/c1-17(24)23(16-18-10-6-8-14-21(18)25-2)20-13-7-9-15-22(20)26-19-11-4-3-5-12-19/h3-15H,16H2,1-2H3/i2-1\")",
          "function": "Abundance",
          "id": "8fdafa466859a5b61aeb791c8e5b4e79d6db9cb307b1164f9a93f9d44410b5543206ca688e297fa69db0d7d2adaa0dd490e44c091e6f9797b3ff5358d82abb42",
          "name": "InChI=1S/C22H21NO3/c1-17(24)23(16-18-10-6-8-14-21(18)25-2)20-13-7-9-15-22(20)26-19-11-4-3-5-12-19/h3-15H,16H2,1-2H3/i2-1",
          "namespace": "InChI"
        },
        {
          "bel": "p(HGNC:TSPO)",
          "function": "Protein",
          "id": "2611e635c3a45e354fb0ee8f6d31346e32943ee054a5552cc14e9ff1a216528556a969bc31695c59821d390d9fbf7c9e454c50fae9d19cd0f31043c45ddbe2a6",
          "name": "TSPO",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:MAPK1), p(HGNC:NRGN))",
      "function": "Complex",
      "id": "81f10e7e306e4533b5da6b7719fd4db559859a6d4cb2d2383dc7ec189ed2552bd0f361032e5c3090c70e0806822cae7b2a4125c38944244f4936d29ff4cff496",
      "members": [
        {
          "bel": "p(HGNC:MAPK1)",
          "function": "Protein",
          "id": "1f8d432cf371d5eab6afc6946ffa43477e7ed01706159de18b753e9b1c0c993d6369c6f3bb636353986cf45a6554a4cc62c298e4a08211447fe23ff71bc8d48a",
          "name": "MAPK1",
          "namespace": "HGNC"
        },
        {
          "bel": "p(HGNC:NRGN)",
          "function": "Protein",
          "id": "d99fd907c4b6d506d87accf51862b48382d790b5207cbdb6b724648e9f14cde39377aed1bf76cf61d5702c2f9efb2bcc462f3d3e194df47a9833e5a4cf9c0795",
          "name": "NRGN",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(g(DBSNP:rs1868402), g(DBSNP:rs3785883))",
      "function": "Composite",
      "id": "63476f002be740f7a7896d4154b4f46610389fe5f89670cf4d103af67c18620481fc3bffe0eb713f3aa1a32986b289bdbe89a914e5b26f3a5b4833dffce570cc",
      "members": [
        {
          "bel": "g(DBSNP:rs1868402)",
          "function": "Gene",
          "id": "e794d5e0ea99d107120ba23a443a3a7cde270875fe0e473ab5bbdd2a4a5e0f0b0a4ff34f964d1c4b4eb1f1fe52876042d852e40b410c512a6c407d9c11d5badf",
          "name": "rs1868402",
          "namespace": "DBSNP"
        },
        {
          "bel": "g(DBSNP:rs3785883)",
          "function": "Gene",
          "id": "b9547fcb8a9b7f53d72342a4b0772272d327a32656929b0616b03f9a3ef3174b19d4a17f17f540d7cd177ddb0640e06a27ddb102552dd7a0b57d3a2260ca7a6a",
          "name": "rs3785883",
          "namespace": "DBSNP"
        }
      ]
    },
    {
      "bel": "g(DBSNP:rs113986870)",
      "function": "Gene",
      "id": "a9c6bf83008c9009fe3add7a0dab11fcd3da2861000852ecb40ef607abb5f5a9c7a6912ca4269c02132f39d676eef38c0b40de359a5568355fa6e92e31725cd3",
      "name": "rs113986870",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs1801132)",
      "function": "Gene",
      "id": "f945a8fcbc3566183994e6e85c06400fec1522c567b24fdf2ade20a06a6824501bd3280c9c7ec8d3d6f49cd99ecf949088d526da0e4fe4277b614fb2a46ceb88",
      "name": "rs1801132",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs1868402)",
      "function": "Gene",
      "id": "e794d5e0ea99d107120ba23a443a3a7cde270875fe0e473ab5bbdd2a4a5e0f0b0a4ff34f964d1c4b4eb1f1fe52876042d852e40b410c512a6c407d9c11d5badf",
      "name": "rs1868402",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs2179922)",
      "function": "Gene",
      "id": "fdc80bc5bb95babb2b89744322912219f0bb237c6612ccb272995f7e156553daaeb9fb58c29e27b16fd7b51a4ec0f9e626cf76fc64ea006cd2d2120a4d9b20b9",
      "name": "rs2179922",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs22334693)",
      "function": "Gene",
      "id": "396f4825eb03a869bf71cbbbd2db69916d97bdaeb9b4732772ed13c554058269b6a4edc4f8e200ae92c11036e5ab43167c69c5c55b0d4438c35a2254648506a8",
      "name": "rs22334693",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs2732703)",
      "function": "Gene",
      "id": "f52b8501e558b6c2780a4fe2519f225c7aa1202ce315c3735822eb53c9bf0101428f51efe2d15fbb27f22fd3d5c8c1d83314203e6f22d9d74361b60060b38523",
      "name": "rs2732703",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs3785883)",
      "function": "Gene",
      "id": "b9547fcb8a9b7f53d72342a4b0772272d327a32656929b0616b03f9a3ef3174b19d4a17f17f540d7cd177ddb0640e06a27ddb102552dd7a0b57d3a2260ca7a6a",
      "name": "rs3785883",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs3818361)",
      "function": "Gene",
      "id": "6e6052112b1be547867b371313158a9f5b3628ccf439ac5e3c80a311417a25b3c5a96beb0a3c4cbf12dd665929a69545135f396c20ded0a868adb4852aa4beaf",
      "name": "rs3818361",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs3851179)",
      "function": "Gene",
      "id": "b43ce0d6a2ec0871c55a19949247d249dbe1ff6d716d4cec2b5f10430cf767704d08f78a79da4dac12dd7d03b7afe251e389cd337be21a022dc15fa48de5171e",
      "name": "rs3851179",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs3853248)",
      "function": "Gene",
      "id": "ce937e3f4d2ace77df3b78fbaae49c044c2055668459803ebd8f09379195ab5ddda31e7fecc98bc761836b413e14c7b6af73b5664a540f6568033ec5d5f8fb4b",
      "name": "rs3853248",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs429358)",
      "function": "Gene",
      "id": "3c519ff2f0b5f7c5ede86b7fdacd80de6345eee37524c5dafed29b2be2ba8cad33c0be7ef54784f6ccf181069bcd6a4cba4c55d9cd1791534b8507dd9c9f0fc5",
      "name": "rs429358",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs4420638)",
      "function": "Gene",
      "id": "25f1f8985fa811939fe5bdeb99584b644aa966fd671da05b35e5a72a1d4ffc985eb6cfa80a72d3cc2bc41e944c05891a5e3a32dc7ecaf3a4f9f3370506fa5544",
      "name": "rs4420638",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs541458)",
      "function": "Gene",
      "id": "8d853ba308c35d3315f7509b33a7add2b9f0277dd1bf528818d34bd151a206b7b7a2e2d3da2e845074e8eff4ae3efa251cfdcf7c08ac7a6c04e4bc6c55ea4b7e",
      "name": "rs541458",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs744373)",
      "function": "Gene",
      "id": "32f3ab4f0c876fb321f54749352bb294300eba572404471afec726cad2d3f8373ee08782542a6f7873cad1fda9106d0b70bf038585e56f645d0dd2bccfe072b8",
      "name": "rs744373",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs932477)",
      "function": "Gene",
      "id": "73e6571e89d971f2f77fe8104a226097f252a74f6c292b6dcfffe1f83b0ec8587ebca1132a502a74d1595ca44d122354498e55b7dfa233954712c2600dbc2b79",
      "name": "rs932477",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs9340799)",
      "function": "Gene",
      "id": "24651213a57c45cb0b699d904f2102b072c0c0232053722f0dc64b16b201e3e62217b225213487e8e48f3d2dc527b6c82c96a80de456b8056fb535b31f6b6688",
      "name": "rs9340799",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs9341016)",
      "function": "Gene",
      "id": "fb2cdfbe089a1a1eb091f70120ea2690d0370c0e9a302c63585bfa58b36b1a4f14e704360c762c378ad368d598788ad1e254059bacd260f0b5fc47c2a068c144",
      "name": "rs9341016",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(DBSNP:rs9397456)",
      "function": "Gene",
      "id": "1b3e971d3145bfc887fa46a3c0ac8891166cfaf2c46466dc16a63284551c674562cdca4259654ddb070a73e611fb270c5d28d60dc6335767053439e86308573c",
      "name": "rs9397456",
      "namespace": "DBSNP"
    },
    {
      "bel": "g(HGNC:APOE)",
      "function": "Gene",
      "id": "52fffdc387ca42d3a05d3897059675ff2703bf98479addf33ba3eba24c52ee94a34a06d48b5c30c31583e3bf81a921f0128b543346eda9e6dae0e059e59328bb",
      "name": "APOE",
      "namespace": "HGNC"
    },
    {
      "bel": "g(HGNC:APOE, var(\"c.388T>C\"))",
      "function": "Gene",
      "id": "7fa1cc5994dad74c3bed902bc892af869e1587fac8f21b1e1e6792a9d88ec34154c504b84a6115571631dd1276c7ba896f6ed79280988341cb25aa6b3f842b56",
      "name": "APOE",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "c.388T>C",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "g(HGNC:BIN1)",
      "function": "Gene",
      "id": "c96ab532ad3520caf197de7812e5a3892fbc2ba06b2cfc492d14627b14285db7f2d2cbbcb83427a5ce931cb23aa83b44f80d5ada5305310ddb856c5decc0e5c4",
      "name": "BIN1",
      "namespace": "HGNC"
    },
    {
      "bel": "g(HGNC:CR1)",
      "function": "Gene",
      "id": "d8771d37dc96a882a8288e2cbdcdd9a3dccdf72abbc47532e4d8b5376d055f737899529c12df28546b4c34efa0654b2f7d405e9348cd4df7a4adda325a7beebe",
      "name": "CR1",
      "namespace": "HGNC"
    },
    {
      "bel": "g(HGNC:PICALM)",
      "function": "Gene",
      "id": "09db5a305327c89d2319c9045f165f87ebc484d64769e1a2ef5667da2412f0bec8001d9a0666a923f634e3032c13a612db8522f6933fa775cf77456519640e9a",
      "name": "PICALM",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ACTA2)",
      "function": "Protein",
      "id": "14d638182b3edfbde5832dc5fb780457d344f7837fa1d03507e97be6a2168c585441bb9c11be734442a8be590a80ab4e477648f65634359f76b1a85ef8f1e136",
      "name": "ACTA2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ADAM10)",
      "function": "Protein",
      "id": "bd47ad5cb480f1f5352dc919edee75d506c0cbfe44ed1a4c53dd9e9c7f7ab383ca2111205a1c12d47100e58c5a5d80d33a56372524bad144da469c574748e8c1",
      "name": "ADAM10",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APOE)",
      "function": "Protein",
      "id": "b17ad2f45c20f323d56bf6d806eceebc45de815de6578a61f820329d5bba1059af52aa63bfcba2bea3b71985bc404e5fc1bce130012d3c58f3a39023923ffb43",
      "name": "APOE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APOE, var(\"p.Cys130Arg\"))",
      "function": "Protein",
      "id": "0e47715aba0af7d383783407c74460a8367b87af98dce8ab970d36866c630c078bc6810a4ec32e738db44da8380c8803dcb764d0eda193c783c295c95f6180cc",
      "name": "APOE",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "p.Cys130Arg",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "p(HGNC:APP)",
      "function": "Protein",
      "id": "ed1d45f3255226e4210017e6c179950e0e04a300727326d7fea6a9659868e8818ff64fd5e8a2a92a703fb1566b3f48323750ac6c28e7adb40843053d276710bc",
      "name": "APP",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:APP, frag(\"672_711\"))",
      "function": "Protein",
      "id": "7cd67a8af4a0e8ec5892776b4d9ac8146e0569074c0ca2d3d844365df47b15173aeead47cc30a92a1f32cd22264f9bdeb311711bdffed82ff32b41d6224a0a27",
      "name": "APP",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 672,
          "stop": 711
        }
      ]
    },
    {
      "bel": "p(HGNC:APP, frag(\"672_713\"))",
      "function": "Protein",
      "id": "3e5de8e845a1a7b00bc3bcb2e2ce192ad8c91a9c1beb7f894571f750d8d4cbcfb96c2dcabb2c5f461e38a63cd31bbb7233e393cfba29dea19455033cd38fbe28",
      "name": "APP",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 672,
          "stop": 713
        }
      ]
    },
    {
      "bel": "p(HGNC:BACE1)",
      "function": "Protein",
      "id": "88f17e7dffb6947c01414f79e5a3bb9cdd3e932c355af7f0c8907d2b5d07742883eaf63866fe7fc938401ce0c366856fd5e306f324e6c1f474c1a984c8e46a51",
      "name": "BACE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CASP3)",
      "function": "Protein",
      "id": "3fc355e7c574083fad31aa9edc5d5685615c49fd58885c2fbd439371619da84fbe274bd3325695ab21c912b5ea592d8031ffa114a9147908170dc187400ba74c",
      "name": "CASP3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CD82)",
      "function": "Protein",
      "id": "91d1479d03193271c2549609c09d590bd8baeb4a753ec3c12dbc4651c81df06f9c830c5f8ee1a5035c87f29a4a1daed69f84d7e9198634190f4ff171ff146c54",
      "name": "CD82",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:DYRK1A)",
      "function": "Protein",
      "id": "8b164807125f35b205166f36de5783322fc6853c6256711e55eaeb05fd14ffd86288750b3063d01d8bd55376a17dd78d0a7b01fc8b840cb34edbff1b329d72d3",
      "name": "DYRK1A",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:DYRK1B)",
      "function": "Protein",
      "id": "c11ac163d2ef70c208fbeb16414cff7b4eed6a71c306f817044fa8fca1a9e589f41f0c3a876948479ecc737dc5f8663df2d0be0b0336c16777365f9183399f91",
      "name": "DYRK1B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:ESR1)",
      "function": "Protein",
      "id": "e3bd31293c5403b997b5337008759608563f6ae428718ee90f4d614db4eb658a7c4766f27fc82bfa03095977835d87dd4f8fa70918f6f4ad7f866cc67c8ca2c1",
      "name": "ESR1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:GSK3B)",
      "function": "Protein",
      "id": "ac819ecac7786e3ea9b6906b318167c6a94fbbf428aff46f85083b83c50b9604342d39c1c36ff49c2cb3a04e491913164c3e4e7889dedd513b6196d9b0560c7c",
      "name": "GSK3B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KANSL1)",
      "function": "Protein",
      "id": "f9624f3273ab96cf809b75ee85547e591f99e0607de6a42f74b0e9174b846ebb93fa6d0a5a97bc763c5c666deb35a6d2b51ee97c78f60a9d15d71bfb5acc1d76",
      "name": "KANSL1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KAT5)",
      "function": "Protein",
      "id": "3d375019e0fb0a36945e348298375c879c28618bca948ea19aaf33dcbdc82d2c036f0822ce3faea653349ef6800b3199177e28e32a51b08c2fb987ebbc1f277c",
      "name": "KAT5",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:KAT8)",
      "function": "Protein",
      "id": "535cc3bad0262996c913369936fdd8d2c39f897c680021520021f8d108a64347ca1ce6dbea4f381e5c6705c0ae01ca7a877d05a166070a6cbb10cfc9e1117647",
      "name": "KAT8",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPK1)",
      "function": "Protein",
      "id": "1f8d432cf371d5eab6afc6946ffa43477e7ed01706159de18b753e9b1c0c993d6369c6f3bb636353986cf45a6554a4cc62c298e4a08211447fe23ff71bc8d48a",
      "name": "MAPK1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT)",
      "function": "Protein",
      "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
      "name": "MAPT",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"152_*\"))",
      "function": "Protein",
      "id": "dd17e9f86d4bea765f3bd7ea012d362a384c6c3665ba4f11cb02858795d08333990c27fb3ece7a3e4ec189b78abba0fb28b547ea08cbc2a2558a413350254586",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 152,
          "stop": "*"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, frag(\"421_*\"))",
      "function": "Protein",
      "id": "e9811c57653cbb8bc7637dc8b18062bca73f9b5b7cd73d91a975e7e0042da1cabbedc6a82241879224fa757ce64c8e61ce8a2ad313c797f8cb08dc999bdae008",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "kind": "frag",
          "start": 421,
          "stop": "*"
        }
      ]
    },
    {
      "bel": "p(HGNC:MAPT, pmod(Ph))",
      "function": "Protein",
      "id": "526bae251987f8c4f55f6e2451662fa55e087c57585beae7c389b020d73487c739834e9b8ec841783de6a5b5fb9df8b138e9eff4406a9ec5e606766575dcac0e",
      "name": "MAPT",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": {
            "name": "Ph",
            "namespace": "bel"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(HGNC:MME)",
      "function": "Protein",
      "id": "8495cf2e994033c3769854828c023757130813a9381008860adb2cc801bf37359fe1a6b0b00d3b9ef95d354e2e2dd1383299cd272d751421c61fc1eaa151af30",
      "name": "MME",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NEFL)",
      "function": "Protein",
      "id": "a5f1bbc3e8064778d946c4c1779f74e5ff2dad31c0e002c1fcf62969adfebc17df206e38990777acc00961ddb9c21928c4012200136eefacfc0e19eb8d49107f",
      "name": "NEFL",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:NRGN)",
      "function": "Protein",
      "id": "d99fd907c4b6d506d87accf51862b48382d790b5207cbdb6b724648e9f14cde39377aed1bf76cf61d5702c2f9efb2bcc462f3d3e194df47a9833e5a4cf9c0795",
      "name": "NRGN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:S100A9)",
      "function": "Protein",
      "id": "766d7161e6461396428d9baa9dc2f8e40a8756b34364103c8281828aaa92bec984c733a84e454ecd4ff8aada41d08ccc56492b5adbb84ab3d41ffbfe0729eb7a",
      "name": "S100A9",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SERPINE1)",
      "function": "Protein",
      "id": "2f4ac169902eb115fff43ab84109e713460b161a2725f1fa5d6c1fa4bd484cf5b0fc14db2a65d2ad3a602697c5ed283257cf011bbd009bf050ff2c5043e37564",
      "name": "SERPINE1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SLC6A3)",
      "function": "Protein",
      "id": "0c17625032ca4c5c910186e71d24fad371c1cdba5382b9822a211ae4b7fe0a15c142dea309cad92d1a13863788562a40e1166da45959ad05b458eed3ba6f2cc1",
      "name": "SLC6A3",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:SOD2)",
      "function": "Protein",
      "id": "d9de7ac12e118486d41cd813025b0979125d0644f64cdbbd373bd89afb4806f4d51f9821124ddcc573517accdfb053ac846e20fec82ae07b7bfed58044bd3b44",
      "name": "SOD2",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TAGLN)",
      "function": "Protein",
      "id": "0926f834130f68b0d8d6e3392f2b01d453c9686233ef1c7545e8ae7790c5d6e57278458c8189cb197d4fcad2134d39403308a5432e5a86e99e341aa19889a07d",
      "name": "TAGLN",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TP53)",
      "function": "Protein",
      "id": "b3cf9a1d278f5ccc00d85dd03123ef42b4470914b7e279563535c5827c39437c5d9d81e76957b16054df7e83501f04de6ccfad79fcafbc2bc4d417f5c6b814ba",
      "name": "TP53",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TSPO)",
      "function": "Protein",
      "id": "2611e635c3a45e354fb0ee8f6d31346e32943ee054a5552cc14e9ff1a216528556a969bc31695c59821d390d9fbf7c9e454c50fae9d19cd0f31043c45ddbe2a6",
      "name": "TSPO",
      "namespace": "HGNC"
    },
    {
      "bel": "path(EFO:\"late-onset Alzheimers disease\")",
      "function": "Pathology",
      "id": "777074b2bd9c23e08fb26dfb8741bf259f83ded81a1e7f3311139b6bdbcb3e27a59600c0eb9ce6a2d5432f10405805e3a3128e90711acbf0d8b42255ef53c35d",
      "name": "late-onset Alzheimers disease",
      "namespace": "EFO"
    },
    {
      "bel": "path(GO:\"short-term memory\")",
      "function": "Pathology",
      "id": "be0619d1fb9130eead795af7debb9e2218db16746e380924792b727565c58e7b16da26f03b5c95c9778992c49f9b1c696a5fd4d28f6eb1a08ffdfac92e3a0560",
      "name": "short-term memory",
      "namespace": "GO"
    },
    {
      "bel": "path(MESH:Hallucinations)",
      "function": "Pathology",
      "id": "ad73f79878286e99e48ad8b2ff196bd160666327c138014eae6150c76c71e650c37b2e6e083ba61dfda68dd41a788462fb101c654e6ad160cb434a2076b5df14",
      "name": "Hallucinations",
      "namespace": "MESH"
    },
    {
      "bel": "path(SDIS:\"mitochondrial damage\")",
      "function": "Pathology",
      "id": "62ca368dbaccc39bfd8fea08bcd9ae2fa012058d66758c895f85ba1e9ca8ee2f8c2a14745a6cffbaa979939f535122fd0e33f6eee496ba73e76154ca8a4c5d59",
      "name": "mitochondrial damage",
      "namespace": "SDIS"
    },
    {
      "bel": "r(HGNC:APOE)",
      "function": "RNA",
      "id": "f72996149be0069daba0fed32c48daafa0dd1ae759ed1045d84a581c5d42605a49c40aee26f970db66ca7b0c4dbe279a80f38eea135e2ec961eaf2bc6d0cc1db",
      "name": "APOE",
      "namespace": "HGNC"
    },
    {
      "bel": "r(HGNC:APOE, var(\"r.388u>c\"))",
      "function": "RNA",
      "id": "15e16bd2feee2ecdd4fa1164aa4a05ea4a5cbf5d4849964e5799e568dd3423691b690d011cea863763a479a0488b1e8a4edffb6171ed31d974b7a4cf87f74f4f",
      "name": "APOE",
      "namespace": "HGNC",
      "variants": [
        {
          "identifier": "r.388u>c",
          "kind": "hgvs"
        }
      ]
    },
    {
      "bel": "rxn(reactants(p(HGNC:MAPT)), products(p(HGNC:MAPT, frag(\"152_*\"))))",
      "function": "Reaction",
      "id": "62ed7701ad8ad445b5713555b99f9674b4a89dc7fef509a4a492a723075c4ec59e206f9e9794e9f81434bb28efe88b566d04a081cbdb088f2be6c6d72c0b2318",
      "products": [
        {
          "bel": "p(HGNC:MAPT, frag(\"152_*\"))",
          "function": "Protein",
          "id": "dd17e9f86d4bea765f3bd7ea012d362a384c6c3665ba4f11cb02858795d08333990c27fb3ece7a3e4ec189b78abba0fb28b547ea08cbc2a2558a413350254586",
          "name": "MAPT",
          "namespace": "HGNC",
          "variants": [
            {
              "kind": "frag",
              "start": 152,
              "stop": "*"
            }
          ]
        }
      ],
      "reactants": [
        {
          "bel": "p(HGNC:MAPT)",
          "function": "Protein",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
          "name": "MAPT",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "rxn(reactants(p(HGNC:MAPT)), products(p(HGNC:MAPT, frag(\"421_*\"))))",
      "function": "Reaction",
      "id": "456b5772e1ab6945c530d8dc5ee15513d966ed232d3f5a4c6ad07a79566c1264bc7da29d30b6bd2167845d8a43dbe9d503e1a096463f0f8a7f320f882ce8bc1b",
      "products": [
        {
          "bel": "p(HGNC:MAPT, frag(\"421_*\"))",
          "function": "Protein",
          "id": "e9811c57653cbb8bc7637dc8b18062bca73f9b5b7cd73d91a975e7e0042da1cabbedc6a82241879224fa757ce64c8e61ce8a2ad313c797f8cb08dc999bdae008",
          "name": "MAPT",
          "namespace": "HGNC",
          "variants": [
            {
              "kind": "frag",
              "start": 421,
              "stop": "*"
            }
          ]
        }
      ],
      "reactants": [
        {
          "bel": "p(HGNC:MAPT)",
          "function": "Protein",
          "id": "ad82d360f02888e890bb2d1f91d1dc020c21cebed2b4eed0193a58e6b396b5f0797d607568dea382c05ffe2a003537d10190b020739af8d51c8d7dbc19bf5ab1",
          "name": "MAPT",
          "namespace": "HGNC"
        }
      ]
    }
  ]
}